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Abstract 
 
RNA interference (RNAi) is a wide-spread gene silencing mechanism that control diverse 
biological functions and triggered by small interfering RNAs (siRNAs) processed from the viral 
genome or its replication intermediates. Mechanistic studies of antiviral RNAi in Caenorhabditis 
elegans has led to the identification of several critical factors involved in the process. As a result, 
whether antiviral RNAi requires additional novel genes remains to be an open question. 
Viruses are intracellular parasites that rely on host products for reproduction. Disrupting 
their interaction with host factors can significantly compromise their replication and keep them 
under control. Thus, identification of host genes involved in viral genome replication will facilitate 
the development of antiviral drugs. 
In this dissertation, I present how I designed and conducted genome-wide genetic screens 
to look for novel worm genes required for antiviral immunity and viral genome replication.  
To identify novel factors required for antiviral RNAi but not for classical RNAi, a reporter 
worm strain containing four transgenes corresponding to known antiviral RNAi gene was 
developed for a biased genetic screen. It was expected that any loss-of-function alleles derived 
from these four known genes will be automatically rejected during the screen. Altogether 25 
candidate alleles were identified and assigned to 2 known antiviral RNAi genes and 11 novel 
genes. Specifically, rsd-6 was confirmed as one of the candidate genes through mapping-by-
sequencing strategy and 2 candidate genes as key requirement of antiviral RNAi but dispensable 
for classical RNAi. I believe that these 2 candidate genes are novel antiviral RNAi genes since 
drh-1 is so far the only one that falls into this category and has been excluded during the screen.  
To look for worm genes required for Orsay virus genome replication I used a triple mutant that 
carries the FR1gfp replicon transgene as reporter for loss of viral genome replication. The 
 viii 
transgene-mediated viral genome replication also ensures that no false positive mutants will be 
picked up because of failure in virus genome replication initiation. Altogether 16 candidate 
alleles were identified and assigned to 12 novel genes. Most importantly, I found that most of 
these 12 candidate genes also play essential role in directing the genome replication of Orsay 
virus, which naturally infects C. elegans. To my knowledge, this is the first work that has 
successfully led to the identification of critical worm factors required for viral genome 
replication. 
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Chapter 1. General Introduction 
 
1.1 Virus Replication in Caenorhabditis Elegans 
 
1.1.1 Virus Replication in General 
 
Viruses are obligate intracellular parasites that can only reproduce themselves in living 
cellular organisms (Chinchar, 1999). In animal cells, 103 to 105 virions can be replicated within a 
short viral replication cycle, ranging from a couple of hours to at most a few days. According to 
the Baltimore classification system, there are 7 different classes of viruses based on their genome 
constitution (DNA or RNA) or their replicating strategy: Class I, double-stranded DNA (dsDNA) 
viruses; Class II, single-stranded DNA (ssDNA) viruses; Class III, double-stranded RNA (dsRNA) 
viruses; Class IV, plus-stranded RNA (+ssRNA) viruses; Class V, minus-stranded RNA (-ssRNA) 
viruses; Class VI, retroviruses; Class VII, pararetroviruses (Baltimore, 1971).  
Typically, a complete virus replication cycle involves attaching to and penetrating host 
cells, uncoating the nucleic acid genome, replicating virus genome, synthesizing virus protein, 
assembling components, egressing new viruses via budding or cell lysis (Whittaker et al., 2000). 
Both host and viral enzymes catalyze virus genome replication and the relative contribution differs 
between the types of DNA or RNA viruses. Viruses with DNA genomes utilize host-encoded PoI 
II to transcribe their genomes in the nucleus of host cells except for poxviruses, which replicate in 
the cytoplasm. Besides, viruses with RNA genome utilize virus-encoded RNA-dependent RNA 
polymerase to synthesize their genomes in the cytoplasm of host cells except for retroviruses, 
which replicate in the nucleus (Ackermann et al., 1998). To minimize the burden of virus genome 
size and maximize the rate of synthesized virus proteins, one viral mRNA is often used to encode 
one or more proteins. Virus protein synthesis is thoroughly dependent on host cell translation 
machinery. Since the structure of virus mRNAs is similar to that of host mRNAs, viral mRNAs 
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can serve as translation templates and exploit host translation factors to compete or suppress the 
host's translation process (Nagy and Pogany, 2012). 
Studying the virus replication is essential for a proper understanding of antiviral drug 
design and controlling virus diseases.  Unlike the plant viruses that need to pass through cell walls, 
animal viruses usually enter cells in two different ways, either by receptor-mediated endocytosis 
or by changing its shape to fuse with the cell membrane and enter the cell (Goldstein et al., 1979; 
Marsh, 1984). The attachment sites or receptors required for virus entrance are unique and distinct 
enough to be recognized by each class of viruses. Thus, antiviral drugs can be designed to block 
the viral attachment process. For example, the inhibitor Enfuvirtide (T-20) was shown to inhibit 
virus entry by disrupting the fusion of HIV particles lipid envelope to host cell plasma membrane 
(Kilby and Eron, 2003). It is worth noting that many viruses, especially RNA viruses, keep 
evolving and changing over the years or even months. As such antiviral drugs/vaccines need to 
follow up with the “updated-version” virus. This is why new flu vaccines are released every half 
or one year to keep up with the rapidly changing flu viruses. One way to mitigate virus evolution 
is to target host factors for drug development: although the viral genome may keep changing during 
evolution over time, host genes encoding factors required for viral replication evolve at a much 
lower rate and all mutant viruses have to maintain the conformation needed to interact with host 
factors. Thus, drugs designed to disrupt virus-host interaction holds the promise to inhibit the 
emergence of drug-resistant mutant viruses.  
The replication cycle of a +ssRNA virus can exploit a significant fraction of 20,000-30,000 
host proteins (Nagy and Pogany, 2006). Thus, identification of host molecules that participate in 
each step of virus replication could provide valuable new targets for antiviral therapy. However, 
this goal may take several decades to achieve with conventional forward genetic screen methods 
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in mammalian cell cultures. It is also challenging to evaluate the safety and efficacy of drugs as 
inactivating one or more of these host key genes may be lethal to the animal host. A traditional 
approach to find viral replication requirements is the systematic RNAi screen based on yeast 
single-gene-knockout banks (Nawaz-ul-Rehman et al., 2013; Panavas et al., 2005). However, 
considering the genetic distance between yeasts and humans, host factors identified in yeasts may 
not be conserved in humans or may not contribute to the same function. 
1.1.2 Plus Stranded RNA Virus Replication in General 
 
Among these seven virus classes, class IV viruses, namely +ssRNA viruses, constitute the 
largest group of known viruses. Approximately 70% of plant viruses are +ssRNA viruses. A large 
group of mammalian +ssRNA virus, such as covid-19 coronavirus, SARS coronavirus, hepatitis 
virus C, West Nile virus, and dengue virus, are lethal pathogens to human beings.  +ssRNA viruses 
have compelling infection advantage over -ssRNAs and DNA viruses because the genomes can 
function as mRNAs (Dreher and Miller, 2006; Simon and Miller, 2013).  +ssRNA virus genomes 
encode RNA-dependent RNA polymerase (RdRP), a viral protein that synthesizes RNAs from an 
RNA template. In general, +ssRNA viruses can infect and enter host cells via either endocytosis 
(animal cells) or wounds (plant cells), where the viruses genomic RNAs are released in the 
cytoplasm after the entrance. Almost instantly, they are translated into viral replication complex 
(VRC) proteins by exploiting host cell ribosomes. VRC then synthesizes the complementary RNAs 
that function as the templates for synthesizing numerous +ssRNAs. During the replication process, 
the intermediate products, dsRNAs and sub-genomic RNAs, are created as well.  Viral dsRNAs 
may trigger potent antiviral RNAi response. The newly synthesized +ssRNAs turn into new 
templates for the next cycle of replication and translation, or undergo encapsulation, coating 
processes and egress from the animal cells or move between plant cells. 
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1.1.3  Orsay Virus Replication in C. elegans 
 
In 1974, Sydney Brenner was the first researcher to suggest Caenorhabditis elegans as a 
genetic model to study modern molecular biology in laboratory setup (Brenner, 1974). C. elegans 
now is widely employed as model system in over a thousand laboratories worldwide. C. elegans  
worms are small, free-living nematodes found in soil, compost heaps, rotting fruits, and snails 
(Barrière and Félix, 2007). They are 0.25 millimeters long for the newly hatched larvae and 1 
millimeter for the adults. C. elegans can be maintained cost-effectively on agar plates seeded with 
a lawn of Escherichia coli OP50 strain. These features make C. elegans an ideal model to study 
the host-virus interactions.  
Orsay virus is so far the only known natural virus that can infect C. elegans. In laboratories, 
Orsay virus infection can be achieved by feeding worms with the mixed Orsay virus filtrates and 
OP50 bacteria liquid. Orsay virus is a typical class IV virus and a member of the Nodavirus family. 
This virus was first discovered in a natural mutant strain named JU 1580 (Félix et al., 2011a). 
Orsay virus is a non-enveloped virus with a plus-stranded bipartite RNA genome, made of two 5’ 
capped and 3’ non-polyadenylated RNA segments, termed RNA1 and RNA2 (Félix et al., 2011a) 
(Figure 1.1.). RNA1 genome segment is about 2.68kb in length and encodes an RdRP while RNA2 
 
Figure 1.1. Schematic of Orsay virus genomes. Orsay virus genome RNA1 encodes RNA-
dependent RNA polymerase (RdRP).  RNA2 encodes a viral capsid protein at 5’ end and a 
capsid-delta fusion protein with unknown function at 3’ end, which is generated by a 
frameshifting mechanism. 
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is about 2.36kb and encodes both a viral capsid protein and a fused delta protein with unknown 
function.  The delta protein is generated by a ribosomal frameshifting mechanism (Jiang et al., 
2014b) (Figure 1.1.).  
In wild type worms, Orsay virus replication level is extremely low due to the existence of 
antiviral RNA interference (RNAi).  In RNAi defective worm mutant Orsay virus infects intestine 
tissue and accumulates to high level, making it easy to detect them through Northern blotting  
(Franz et al., 2014) (Figure 1.2. A). Interestingly, the intestine-specific infection pattern remains 
unchanged when Orsay virus is delivered as a transgene into RNAi defective worms either with or 
without transgene reporter (Jiang et al., 2014a) (Figure 1.2. B). This finding suggests that a 
receptor-independent mechanism limits the Orsay virus infection in different types of cells 
throughout whole body of C. elegans. 
 
 
Figure 1.2. Orsay virus infection pattern and virus RNA accumulation in wildtype N2 worms 
and RNAi defective worms. (A) Orsay virus is isolated from JU1580 strains and infects N2 
and drh1; rde1 double mutant worms. (B) Transgenic worms 46; N2 and 46; drh1; rde1 carry 
Orsay RNA transgenes and its expression can be induced by heat induction.  Infection pattern 
in both worm strains was detected by FISH (top) and Orsay RNA accumulation level was 
detected by Northern blot (bottom). 
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1.1.4 Current Study on Orsay Virus Replication in C. elegans 
 
As discussed above identification of host factors involved in virus replication may facilitate 
the development of antiviral therapeutics. The discovery of Orsay virus as a natural viral pathogen 
of C. elegans makes C. elegans a great genetic model system for the identification of host factors 
contributing to virus replication. Using an Orsay virus infection inducible transgene as a reporter 
David Wang and colleagues have identified three worm genes as key regulator of cell entry. 
However, host genes involved in virus cell entry usually function in a virus-specific way, namely 
host gene required for cell entry of a virus usually does not facilitate the cell entry of another virus. 
Thus, antiviral drugs targeting host factors engaged in virus cell entry do not confer wide-spectrum 
antiviral activities.  
All of the RdRP proteins produced by class III, IV and V viruses contain conserved 
domains, suggesting that many RNA viruses may share a set of common host factors for genome 
replication. Antiviral drugs targeting these host factors may confer wide-spectrum antiviral 
activities. Thus, it is of great interest to identify host factors involved in viral genome replication.  
So far, the development of Orsay virus replicon that can express a reporter gene, such as 
GFP or mCherry gene, has been unsuccessful, making it impossible to use Orsay virus as reporter 
of loss of viral genome replication. However, a flock house virus (FHV) based replicon has been 
successfully developed to express GFP reporter gene upon successful replication in C. elegans. 
FHV belongs to the same viral family as Orsay virus and thus may share the same set of host 
factors for genome replication. The replication of the FHV based replicon, termed FR1gfp, can be 
easily initiated from a transgene through a simple temperature shift, making it possible to 
simultaneously initiate viral genome replication in hundreds of thousands worms and no false 
positive will be produced because of failure in virus inoculation.  
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1.2 Antiviral Innate Immunity in C. elegans 
 
1.2.1.  Antiviral Innate Immunity in Diverse Organisms  
 
Viruses are highly infectious parasites that can cause various diseases in host organisms. 
To counteract fast evolving viral pathogens cellular hosts have evolved a broad spectrum of 
antiviral defense mechanisms. In eukaryotes, RNAi is a conserved ancient process where the small 
interfering RNAs (siRNAs) or the micro RNAs (miRNAs) works in a sequence-specific manner 
to seek homologous RNA transcripts and cause translation inhibition or denaturation on the targets. 
In fungi, plants, and invertebrates, virus-derived siRNAs guide strong silencing of invading virus 
transcripts to suppress virus replication (Elbashir et al., 2001; Grishok et al., 2001; Sharp, 2001). 
Because many of the core components involved in antiviral RNAi can be found in all eukaryotes, 
it is thought that antiviral RNAi predated the evolvement of diverse innate immune responses in 
diverse organisms. It is interesting that during the evolution, fungi, insects, and worms keep 
antiviral RNAi mechanism as a major innate immune response, while plants and vertebrates 
maintain not only antiviral RNAi but also other newly evolved innate immune responses, such as 
the gene-for-gene immune response in plants. 
In plants, antiviral RNAi is a major innate immune response. Meanwhile, other innate 
immune responses, such as the pathogen-associated molecular pattern (PAMP)-triggered 
immunity (PTI) and effector-triggered immunity (ETI) (Dangl et al., 2013; Schwessinger and 
Ronald, 2012; Spoel and Dong, 2012; Zvereva and Pooggin, 2012), are also employed in 
counteracting virus replication. PAMPs can be viral genomic materials, replication intermediates, 
transcripts, or glycoproteins. Plant viruses are delivered into the host cells by insect vectors or 
through mechanical wounds. The long-distance transportation of PAMPs from cell to cell requires 
signals and receptors, which involves plasma membrane-localized and intracellular immune 
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receptors (Dodds and Rathjen, 2010; Zipfel, 2014). The plasma membrane-localized pattern 
recognition receptors activate PTI, and ETI is activated by virulence effectors secreted by 
pathogens into the intracellular host environment (Böhm et al., 2014; Calil and Fontes, 2017; 
Gouveia et al., 2017; Jones and Dangl, 2006; Macho and Zipfel, 2014). PTIs participate in the first 
step and are triggered by viral glycoproteins to limit viral infection. ETIs are involves in the second 
step and triggered by viral genomic materials to inhibit viral genome replication. 
In vertebrates, the emergence of interferons (IFN) immune response and recombinational 
adaptive immune systems become the primary antiviral mechanism in somatic cells, while the 
antiviral RNAi retreats its importance in defending against viral pathogens. Viral PAMPs can be 
detected by host IFN cellular pattern recognition receptors (PRPs) and trigger antiviral signaling 
(Seth et al., 2006; Tripathi and Garcia-Sastre, 2016). PRPs mainly include Toll-like receptors 
(TLRs) and retinoic acid-inducible gene I (RIG-I)-like receptors. TLRs present either on the cell 
membrane to detect viral glycoproteins or in the endosomes to detect viral nucleic acid and lead 
to the activation of IFN by activating transcription factors NF-κB, IRF3, and IRF7 (Akira and 
Takeda, 2004); RIG-I like receptors present in the cytosol to detect viral dsRNAs and cause the 
induction of IFN by activating adaptor protein MAVS (Yoneyama et al., 2004).  
1.2.2. PTGS and the Discovery of Antiviral RNAi 
 
Historically, RNAi was also known as co-suppression in worms, post-transcriptional gene 
silencing (PTGS) in plants, and quelling in yeasts.  Although the experimental setup differs from 
each other for those phenomena the genes involved, as revealed by mechanistic studies, were found 
to be the same. In 1990, the homology-dependent gene-silencing phenomenon was first observed 
by Napoli and colleagues. Initially, Napoli expected to enhance the petunia flower purple color by 
delivering the pigmentation genes chalcone synthase (CHS) into the transgenic plant harboring the 
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CHS copies. Unexpectedly, the flower purple color was not enhanced by the extra copies of the 
pigmentation genes. It showed different pigment patterns: the diminished purple color, purple 
mixed with white color, and enhanced pure white color. This led them to hypothesize that 
“cosuppression” phenomenon is induced by the delivery of additional transgene CHS (Napoli et 
al., 1990). At that time, antisense RNA was also considered as the primary trigger of this type of  
phenomenon, also termed “quelling”, since they believed that antisense RNA could hybridize with 
mRNA and cause the inhibition of mRNA translation (Cogoni et al., 1996; Cogoni and Macino, 
1999a, b). In 1995, RNAi phenomenon was first reported in the animal. Guo and Kemphues 
delivered the antisense RNA to par-1 mRNA in C.elegans to inhibit par-1 gene expression, and 
the sense RNA was used for control. Surprisingly, par-1 sense RNA, which would not hybridize 
with mRNA, also induced par-1 gene expression loss as well (Guo and Kemphues, 1995). They 
inferred that the antisense RNA could not be the actual trigger for mRNA degradation. In 1998, 
Fire and Mello tested the hypothesis by injecting the highly purified unc-22 sense RNA, antisense 
RNA, and double-strand RNAs (dsRNAs) in C. elegans and fund out the dsRNA-induced gene 
silencing is 10- to 100- fold stronger than the single-stranded RNA (ssRNA)-induced unc-22 gene 
silencing. Thus, Andrew Fire and Craig Mello were the first to unveil that the real trigger for 
“cosuppression” or “quelling” is dsRNA. They reasoned the false gene silencing phenomenon that 
induced by antisense RNA was actually due to  dsRNA contamination, which may generated 
during the purification of ssRNA procedures (Fire et al., 1998). In 2006, Andrew and Craig were 
awarded Nobel Prize in Physiology or Medicine for their work in underlying mechanism of RNAi 
phenomenon in C. elegans. 
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1.2.3. Antiviral RNAi in C. elegans 
 
1.2.3.1.  Biogenesis and Function of Primary Viral siRNAs (vsiRNAs) 
 
Both RNAi and interferon (IFN)-based innate immune response are triggered by virus 
dsRNA. Antiviral RNAi serves as a major innate immune response in lower level organisms such 
as fungi, plants and invertebrates, while IFN response is dominant in higher level organisms such 
as vertebrates (Lu et al., 2005; Segers et al., 2007; Wilkins et al., 2005). Interestingly, recent studies 
showed that antiviral RNAi could be detected in RNA virus infected-undifferentiated mammalian 
cells or suckling mice (Li et al., 2013; Maillard et al., 2013). In C. elegans, the heritable sequence-
specific immunity response RNAi is a dominant antiviral mechanism. The feature of lacking 
adaptive immune response in C. elegans makes it is an ideal model system to study RNAi-directed 
viral immunity in animals.  
In C. elegans, viral genome or dsRNA replication intermediates, which are often generated 
during the RNA virus genome replication, can trigger antiviral RNAi response. Foreign dsRNAs 
can be recognized and bound by nematode dsRNA binding protein RDE-4 protein, which interacts 
with the potential virus sensor, DRH-1 (Dicer-like RNA helicase 1) (Ermolaeva and Schumacher, 
2014). DRH-1 was believed to detect viral dsRNA and help dicing complex move along on the 
long dsRNA while unwinding dsRNA (Coffman et al., 2017; Guo et al., 2013a). RDE-4 can 
capture unwound dsRNAs and help pass dsRNAs to DCR-1 protein, the only Dicer protein in 
worm. DCR-1 can process viral dsRNA into predominately 23bp short dsRNAs, termed primary 
siRNA, with 2 nt overhang at its 3’ end (Ketting et al., 2001; Lu et al., 2009a; Tabara et al., 2002). 
RDE-1 is one of the worm Argonaute (Ago) proteins that is a key member of the RNAi induced 
silencing complex (RISC). RDE-1 recruits one strand of the siRNA duplex, named as guide strand. 
The guide strand can be utilized as a reference for the RISC to target complementary viral genomes 
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or transcripts leading to the silencing or inhibition of virus replication (Lu et al., 2005; Schott et 
al., 2005; Tabara et al., 2002; Wilkins et al., 2005) (Figure. 1.3). 
1.2.3.2. Biogenesis and Mechanism Secondary vsiRNAs 
 
            With the help of the worm RNA-dependent RNA polymerase (RdRP) protein, RRF-1, 
secondary siRNAs are generated to magnify the antiviral RNAi immune response in C. elegans 
(Figure. 1.3). Genes encoding RdRP have not been found in insects or mammals but are conserved 
in plants and worms. RdRP protein functions downstream of RISC formation and is mainly 
responsible for secondary type siRNA synthesis (Sijen et al., 2001; Smardon et al., 2000). Notably, 
in C. elegans secondary siRNA accumulation level is much higher than that of primary siRNAs 
and secondary siRNA induced slicing activity is far more efficient as well. The family of RdRP in 
plants, also named as RDP, has six members to meet the demand of secondary siRNA production. 
Four RdRP members are found in C. elegans genomes: ego-1, rrf-1, rrf-2, and rrf-3 (Sijen et al., 
2001; Simmer et al., 2002). The drh-3/rrf-1 complex is responsible for the secondary 22G-siRNA 
synthesis and works with the presumable slicer CSR-1, an Argonaute protein required for 
synthesizing secondary siRNA and plays a significant role in the destabilization of target mRNAs 
(Aoki et al., 2007).   
1.2.3.3. Systemic RNAi in C. elegans 
 
               Classical RNAi in C. elegans refers to RNAi triggered by dsRNA introduced via 
feeding, soaking, or localized microinjection. The RNAi effect can be observed in distant tissues 
received no dsRNA trigger  or the whole body (Maeda et al., 2001). This phenomenon, often 
referred to as systemic RNAi, suggests the dsRNA induced a silencing signal which can be 
transported across cell membranes and move across long distance between tissues. 
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Systemic RNAi defective (SID) -1 protein is identified as a transmembrane protein that 
forms the pores and channels for transporting RNAi signals in and out of the cells without ATP 
consumption. This is a passive process. sid-1 mutants are resistant to environmental RNAi but are 
defective in spreading silencing signals between cells and tissues. Interestingly, sid-1 mutants can 
transport silencing signals across the intestinal cell, suggesting that SID-1 is not required for 
ingested dsRNA transporting across intestinal lumen (Feinberg and Hunter, 2003; Shih et al., 2009; 
Winston et al., 2002). SID-2 is a small single-pass transmembrane protein localized on the 
intestinal lumen function as a receptor for importing environmental dsRNA (McEwan et al., 2012; 
 
Figure 1.3. Antiviral RNAi immune response in C. elegans. Antiviral RNAi is triggered by 
virus long dsRNA, which are bound by RDE-4, detected by DRH-1, and cut by DCR-1 into 
primary siRNAs of 23bp, with 2 nt overhang at 3’end. Guide strand is loaded into the RISC 
complex and serves as reference to find cognate mRNAs for degradation or secondary 
siRNA induction. With the help of the RRF-1, secondary siRNAs are generated to magnify 
the antiviral RNAi response. 
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Winston et al., 2002; Winston et al., 2007). Like SID-1, SID-3 exists in most tissues and is required 
to import silencing RNAi signals back into the intestine cells or to distant tissues. However, it is 
not clear whether SID-3 interacts with SID-1 in the same pathway (Jose et al., 2012). SID-5 acts 
differently than SID-1, SID-2, and SID-3. It functions in a SID-1-independent systemic RNAi 
pathway to transport the ingested RNAi signals across intestine cells (Hinas et al., 2012). RNAi 
spreading defective(RSD)-2, RSD-3, RSD-6, and MUT-16 proteins are reported not essential for 
the uptake of dsRNA from the gut into somatic cells, but important for the further distribution of 
ingesting dsRNA into germline (Ketting et al., 1999; Tijsterman et al., 2002; Tijsterman et al., 
2004; Tops et al., 2005; Vastenhouw et al., 2003). Interestingly, from my work, high level of FHV 
and Orsay virus RNA were detected in rsd-6 mutant and the other two novel gene mutants, 
suggesting that the antiviral RNAi signal may be systemic in C. elegans. 
Currently it is arguable whether antiviral RNAi goes systemic in C. elegans. Our previous 
study suggests that RSD-2 in RDE-4-independent antiviral RNAi likely act with RRF-1 to 
stimulate secondary viral siRNAs, which may help boost systemic antiviral RNAi  (Guo et al., 
2013b).  
1.2.3.4. Transgenerational RNAi in C. elegans 
 
Transgenerational RNAi in C. elegans refers to the inheritance of the parental RNAi effect 
transferred with the oocyte or sperm as a dominant factor for two or more generations (Grishok et 
al., 2000). The heritability is not consistent throughout all the generations. It seems to undergo a 
bottleneck after three or four generations and the phenotype is reversed to the same as a wild type 
after the tenth generation. 
 Virus induced siRNAs can trigger robust antiviral RNAi response to silence virus 
replication in parental worms, and these induced siRNAs can be transgenerational transmitted in 
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a template-independent manner throughout progenies aiming to silence viral replication at early 
stage in trans (Rechavi et al., 2011b). The transgenerational antiviral RNAi effect is inherited in a 
non-Mendelian manner from parental worms to progenies to protect offspring from the same virus 
infection in early stages. Transgenerational antiviral RNAi signals may provide adaptive benefits 
in animals. However, recently, it was shown that antiviral RNAi signals induced by the Orsay virus 
infection is not transgenerational  (Ashe et al., 2015), which is in sharp contrast to Rechavi’s work 
(Rechavi et al., 2011b). 
Worm Argonaut protein RDE-1 and double-strand RNA binding protein RDE-4 are 
essential for enabling RNAi transgenerational transmission. Antiviral RNAi is proved to be 
defective in parental rde-1 single mutant and partially defective in rde-4 single mutant. For the F1 
and F2 generations derived from either rde-1 or rde-4 single mutant environmental dsRNA, such 
as dsRNA feeding, induced transgenerational RNAi effect remains active in rde-4 progenies, and 
the transgene virus, like FR1gfp, induced transgenerational RNAi is active in both single mutant 
progenies (Grishok et al., 2000; Rechavi et al., 2011a). Recently a study showed that a 
transgenerational RNAi effect was not observed when worms are infected by Orsay virus (Ashe et 
al., 2015). Probably, the transgene nature of FR1gfp is responsible for the transgenerational effect.  
1.2.4. Virus-induced Gene Silencing in C. elegans 
 
Virus induced gene silencing (VIGS) was first observed in virus-infected plants. The 
infected plants then became resistant to the infection by a closely related or the same virus (Napoli 
et al., 1990). Initially, VIGS is exclusively used to study plant gene function by specifically 
knocking down the expression of target genes (Baulcombe, 1999).  Now it is widely conducted 
with many newly developed viral vectors to study host-virus interactions. For example, modified 
tobacco rattle virus (TRV) and potato virus X (PVX) are found to be able to induce potent VIGS 
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targeting homologous genes upon successful infection in plants (Lu et al., 2003a; Lu et al., 2003b; 
Ratcliff et al., 2001; Ruiz et al., 1998). 
VIGS phenomenon in C. elegans was found to be inheritable in progenies, suggesting the 
possibility that VIGS leads to epigenetic consequences in next generations (Guo et al., 2012; 
Tanguy et al., 2017). In C. elegans, in addition to RDE-1 and RDE-4, RNA-dependent RNA 
polymerase RRF-1 is a key component of RNAi responsible for generating single-strand secondary 
siRNAs in a Dicer-independent manner. In our recent studies, VIGS phenomenon in C. elegans 
can be successfully triggered by delivering FR1gp, which only carries a partial GFP coding 
sequence, into the transgenic wild type worms carrying a gfp transgene. However, the VIGS 
phenomenon did not occur in either rde-1 or rde-4 mutant worms but was observed to a lesser 
extent in rrf-1 mutant compared to wild type worms (Guo et al., 2012). These results together 
suggested that both primary and secondary siRNA mediate target destruction in VIGS in C. 
elegans.  
Recently, it has been demonstrated that the mechanism involved in VIGS is also 
responsible for the induction of viral diseases in plants (Shimura et al., 2011; Smith et al., 2011). 
Although animal virus-encode microRNAs have been shown to influence host gene expression to 
facilitate virus infection, it remains unclear whether VIGS has the potential to modulate host gene 
expression in mammalian (Choy et al., 2008; Hussain et al., 2012; Singh et al., 2012). The C. 
elegans model would be an ideal animal model to address this question. 
1.2.5. The RNAi-independent Antiviral Mechanism in C. elegans 
 
RNAi pathway is one of the best studied pathways that mediates major antiviral response 
in C. elegans. However, additional and novel pathways may exist to confer antiviral immunity in 
worms as suggested by some recent studies. As observed by Tanguy and colleagues, the STA-1-
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dependent pathway may contribute to a novel antiviral pathway in both mammals and worms 
(Tanguy et al., 2017). STA-1 is a transcription factor that belongs to the STAT family and acts as 
a constitutive repressor of antiviral response (Ivashkiv and Donlin, 2014). They found that in 
uninfected animals STA-1 expression is suppressed by SID-3 to maintain an average life span. 
Interestingly, however, SID-3 can reversely induce both STA-1-dependent antiviral pathway and 
RNAi to regulate virus replication upon viral infection. However, how the STA-1 dependent 
pathway works in worms is not well understood yet (Tanguy et al., 2017).  
Pen and colleagues uncovered another novel RNAi-independent antiviral mechanism, the 
CDE-1-dependent innate immune response against Orsay virus replication in worms (Le Pen et al., 
2017). cde-1 is identified as a homologue of mammalian TUT4/7 terminal uridylyltransferase, 
which preferentially uridylates mRNAs with short polyadenylation tail less than 25nt, facilitating 
mRNA degradation (Kwak and Wickens, 2007; Olsen et al., 2006; van Wolfswinkel et al., 2009). 
It is likely that CDE-1 uridylates the 3’-terminus of the Orsay RNA genome and promotes genome 
degradation upon infection of worms. Mammalian TUT4/7 uridylates influenza A virus mRNAs 
after infection in mammalian cells. Consistently, increased Orsay virus or influenza A virus RNA 
accumulation was detected in cde-1 mutant worm or tut4/7 knockdown cells (Le Pen et al., 2017). 
1.2.6. Major Questions Remained to Be Addressed Regarding RNAi-mediated Antiviral 
Immunity  
 
DRH-1 was shown to be required for antiviral RNAi but not classical RNAi, namely RNAi 
induced by artificial dsRNA. Low-level virus-derived siRNAs can be detected in the drh-1 mutants 
through small RNA sequencing (Figure 3.11.) (Coffman et al., 2017). The fact that virus-derived 
siRNAs can trigger sequence-specific silencing of  homologous transgenes in drh-1 mutant (Guo 
et al., 2013a) suggests that viruses are more resistant to antiviral RNAi compared to homologous 
cellular transcripts. Thus, additional genes may be required for antiviral RNAi compared to 
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classical RNAi. Identification and mechanistic study of these unknown genes may shed more light 
on RNAi-mediated antiviral immunity in diverse organisms.  
Orsay virus is the only known natural viral pathogen of C. elegans. To date, a modified 
Orsay virus replicon capable of expressing reporter gene is still unavailable. Therefore, an 
alternative model virus capable of expressing reporter gene is needed for the readout of loss of 
antiviral immunity in the study of worm antiviral RNAi. 
1.3 Objectives of My Study     
 
 My study aims to gain insight into the molecular mechanisms underlying virus-nematode 
host interactions in the context of antiviral immunity and host factors involved in viral genome 
replication. The small size, short life span and hermaphroditic life style of C. elegans makes it an 
ideal system for large-scale genetic screen to identify genes of interest. The FR1gfp replicon can 
initiate efficient replication to express a reporter gene in response to a short temperature shift, 
making it an ideal reporter for viral genome replication and loss of antiviral immune response. 
Thus, the combination of C. elegans and FR1gfp can serve as a powerful system for the study of 
virus-host interactions in the context of viral genome replication and antiviral immunity. 
To identify novel genes with dedicated function in antiviral immunity, we carried out a 
biased genome-wide genetic screen using FR1gfp as loss-of antiviral activity reporter.  Our genetic 
screen identified 25 alleles, which were assigned to 13 genes. Two  of these candidate genes were 
confirmed to be known antiviral RNAi genes, indicating that our genetic screen had great coverage 
on candidate genes. Using a mapping-by-sequencing strategy, we identified one of the candidate 
genes as rsd-6, a gene that helps maintain genome integrity through an endogenous gene-silencing 
pathway but was not known to be required for antiviral RNAi. Importantly, two of my candidate 
genes were found to contribute to antiviral immunity against Orsay but appeared to be dispensable 
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for classical RNAi. Since drh-1 is so far the only gene exhibiting this feature and has already been 
excluded during the screen process it can be concluded that our genetic screen has led to the 
identification of two novel antiviral genes. Mechanistic study of these genes may significantly 
improve our understanding on RNAi-independent antiviral mechanism in nematode worms. 
Using triple mutants carrying the FR1gfp transgene as loss of genome replication reporter 
I carried out a large-scale genetic screen, aiming to identify worm genes required for FHV genome 
replication. At the end of this screen I isolated 16 genetic alleles that compromise FHV genome 
replication. Subsequently I assigned these 16 alleles to 12 different candidate genes through 
genetic complementary tests. More importantly, I found that most of the candidate genes are also 
required, to different extents, for Orsay virus genome replication. To my knowledge, this will be  
the first report on novel worm genes required for virus genome replication. Functional and 
mechanistic study of these candidate genes will not only improve our understanding on virus 
genome replication in general but may also facilitate the development of novel antiviral drugs with 
broad spectrum antiviral activities.  
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Chapter 2. Materials and Methods 
 
   This chapter describes the experimental protocols used throughout this study. Sample 
volumes up to 2.0 ml were centrifuged in microcentrifuge tubes with graduations (VWR), and 
sample volumes from 2.0-14 ml were centrifuged in 14 ml Polypropylene Round-Bottom Tubes 
(BD Falcon). Sample volumes larger than 14 ml were all centrifuged in 50ml centrifuge tube 
(Corning). Autoclaving of chemicals was completed at 121℃ for 30mins. 
2.1.Worms Basics  
 
2.1.1. Nematode Growth Media (NGM) Plates  
 
           C. elegans is maintained on Nematode growth media (NGM) plates containing agar, which 
has been aseptically dispensed with Wheaton Unispense liquid dispenser (Wheaton Science 
Products) on Petri dishes (LabScience, Inc) with different sizes. 1L NGM agar medium is prepared 
with the following protocol (cholesterol, MgSO4 , CaCl2 and Uracil were added after autoclaving): 
 
2.1.2. Worm Food Source  
 
 
         C. elegans is fed with E.coli OP50 strain on NGM plates. OP50 has a limited growth on 
NGM plates, thereby the thickness of the food layer can be manipulated to visualize worm better. 
OP50 is cultured in LB-broth at 37 ℃, overnight, cultured liquid food source can be seeded on the 
dried NGM plates. 
 
 
NaCl Agar      Peptone Cholesterol  
10mg/ml 
1M 
MgSO4 
1M 
CaCl2 
1M 
PPK 
Uracil 
2mg/ml 
ddH2O 
3g 17g 2.5g 0.5ml 1ml 1ml 25ml 15ml Up to 1L 
 
20 
2.1.3. Worm Strains 
 
         The C. elegans isolate, Bristol N2, was used as the reference wild-type strain throughout this 
study. All the worms strains except the temperature sensitive strains were maintained at room 
temperature, 22℃, on standard Nematode Growth Medium (NGM) in Petri dishes with a diameter 
of 35mm, 60mm or 100mm. Mutants derived from N2 strains referred to in the text include drh-
1(tm1329 and ok3495), drh-3(ne4253), rde-1(ne300), rde-4(ne337), rrf-1 (ok589), rsd-2(pk3307), 
rsd-6(nl3300), sid-1(qt2) acquired from CGC (Caenorhabditis Genetics Center) at the University 
of Minnesota-Twin Cities.  
         The genotypes of drh-1 were confirmed by PCR. The rde-1, rde-4 and rsd-2 mutant worms 
were confirmed by using skn-1 feeding RNAi and genomic DNA sequencing. The drh-3 mutant 
allele was sterile at 25°C and thus are selected based on their temperature sensitivity. 11 transgene, 
46 transgenes and 48 transgene array were delivered to stated worm strains and then transferred to 
another background by standard genetic crosses. 
2.1.4. Worm Genetic Crosses 
 
          Males are picked up naturally without treatment or generated by heat shock (37°C for 
45min), or immersed in 15% alcohol (room temperature for 15mins) --intending to avoid virus 
expression if the transgenic worms carry the heat-inducible promoter. All genetic crosses were 
conducted on empty NGM petri dish with 100mM Ampicillin with a small circle of OP50 food, at 
least 20 males and 10 hermaphrodites were selected and put on each plate around food circle. 
About 10 successfully crossing-generated heterozygous F1s were picked up on a new plate with 
fresh food. After 24hrs, 16~20 fully developed adult F2s were randomly picked up and examined 
separately using feeding RNAi, PCR or checking the fluorescence upon heat induction.  
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2.1.5. Worm Microinjection and Transgenic Worms 
 
           Microinjection is used to directly deliver extra DNAs as a broad transgene array in cells to 
generate transgenic worm or induce RNA interference in wildtype C. elegans. The plasmid 
constructs, each of which at a final concentration of 10ng/μl, were mixed with a reporter plasmid 
( PRF4, Pmyo-2::mCherry or Pmyo-3::mCherry ) at a final concentration of 40ng/μl and 2-log 
DNA ladder ( New England Biolabs Inc. ) at a final concentration of 100ng/μl, and injected into 
either arm of the gonads of L4 or young-adult hermaphrodites. Usually, about 70 hermaphrodites 
were injected within one hour and around 50 survival worms were able to produce F1s progenies. 
Young-adult F1s with reporter phenotypes, which carry an extrachromosomal array, were selected 
for further studies or chromosomal integration to generate transgenic worms.     
2.1.6. Worm Chromosomal Integration  
 
           50 young adult or L4 worms that carry extrachromosomal transgene arrays on a medium or 
large plate were treated under 3,500 rad of gamma-ray from a 137Cs source, all 50 fully developed 
adults were killed 8hrs after treatment to keep the eggs only on the plate. 50-100 F1s with 
significant transgenic phenotype were picked up and transferred to a new plate to generate 
offspring. The 700-1000 F3 with most significant transgenic phenotype were selected and 
transferred to small plates one by one for further screening and reconfirmation. Usually, the 
confirmed integrant will be back-crossed 3 times to reduce the non-specific genetic mutations 
caused by the gamma-ray treatment. 
2.1.7. Freezing and Recovery of Worm Stocks  
 
          L1 or L2 stage C. elegans can be frozen and stored indefinitely in liquid nitrogen or -80℃        
freezer. Freshly starved young larvae (L1-L2 stage) from medium or large NGM plates with just 
exhausted OP50 food source were washed with by autoclaved freezing buffer, prepared by the 
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following protocol, and transferred into 1.5ml tubes. After gradually freezing the worm strains on 
the ice first, then they can be safely maintained in liquid nitrogen or -80℃ freezer for long-term  
 storage. 
         The recovery of the freezing tube is achieved by gradually warming up by hand or thawing 
the stored tube on ice. Once the liquid in the tube is defrosted, the worms are ready to be transferred 
on the fresh plate with the OP50 food source, about 30-50% survival larvae worms will be 
observed one hour later. 
2.1.8. Ethyl Methanesulfonate (EMS) Mutagenesis on Worms 
 
           Ethyl methanesulfonate (EMS) induces a comprehensive spectrum G/C to A/T transition 
mutations in the worm genome and is frequently used in forward genetic screen methods. The fully 
developed adult hermaphrodites were first bleached, then enough eggs were collected and 
transferred onto ten 10cm NGM plates. The synchronized L4 or young adult hermaphrodites were 
washed with M9 buffer in a sterile 15ml tube. Worms were spined down at 1000x g for 2 mins and 
the supernatant was carefully removed, then the worms were resuspended with 4ml M9 buffer. 
These steps were repeated 4 times to remove bacteria. Add 2ml M9 buffer and 2 ml of 2x stock 
EMS solution (100mM) in the tube after the fourth wash step, incubate the tube for 6 hours at room 
temperature and gently shake it every 30mins.  Worms are then washed 4 times with 10ml M9 
buffer to remove trace EMS from aliquot, for each wash step, aspirate the supernatant in another 
tube with 1M NaOH to inactivate EMS. Plate treated worms on three 10cm NGM Petri dishes. 
Bleach F1 worms produced from the treated worms and plate eggs on ten 10cm NGM plates. 
Screen the F2 with interesting defects or phenotypes after heat shock treatment. Repeat all of the 
NaCl 1M KH2PO4 Glycerol ddH2O 1M MgSO4 
5.8g 50ml 240ml 710ml 300µL  
 
23 
above steps constituently up to 10 days to screen as many worms as possible to obtain enough 
candidates of interest.                               
2.1.9. Genetic Complementation 
 
         Genetic complementation is conducted to classify if any of two crossed candidates with 
different mutated alleles are going to the same mutated gene or not. Picking up 20 adult males 
from one candidate, and cross with 10 L4 stage L4 hermaphrodites from all of the rest of candidates, 
separately, following the method mentioned in 2.1.4., Mainly check the F1 adult males green 
fluorescence after heat shock treatment; for temperature-sensitive candidates, make a duplicate 
cross and treat F1 worms at 25℃ to see if both parents carry the same temperature-sensitive gene 
mutation. Both of parents from two candidates serve as a negative control, and wild type worm 
have the same transgene are served as a positive control.   
2.1.10. Brood Size Counting 
 
          Developmental defects or growth status is analyzed by a comparison between the brood size 
and physiological status with wild type worms. Originally pick 5 adult hermaphrodites, for each 
strain, on a fresh 10cm NGM plate with OP50 food source at room temperature. Count and record 
developmental and physiological status, and total worm numbers on the plate every day, usually 
from the first day up to seven days, until all candidates of F1 generation grow up to fully developed 
adults. Wild type worm was recorded under the same environment serving as a control.  
2.1.11. Feeding RNAi  
 
         RNAi assay by feeding is used to treat a large number of worms at once to score the gene 
knock-down phenotypes on fed worms or their progenies. First, we prepare E. coli HT115 bacteria 
with transformed plasmid consisting of L4440 vector, then we cloned unc-22, skn-1, gfp or 
interested gene fragment, and culture the bacteria with carbenicillin overnight. 4 hours of IPTG is 
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required before seeding on standard ampicillin NGM agar plates. 20 gravid hermaphrodites were 
placed on feeding RNAi plates to lay eggs at the room temperature. Score the fed worm phenotypes 
until they reach to young- or fully-developed- adults. As a negative control, worms were provided 
with the feeding RNAi bacteria with empty L444 vector that was transformed into the E. coli. 
HT115. 
2.1.12. FR1gfp Induction and Orsay Virus Infection  
 
         Induction of FR1gfp in transgenic worms is conducted by heat shocking synchronized young 
adult worms at 33℃ for 3 hours and then maintaining them at 25℃ up to 48 hours. Green 
fluorescence expression level is observed under a dissecting microscope. The FR1gfp RNA 
extraction is collected from 3 medium plates of each worm strain after fluoresce observation. 
           Orsay virus is prepared by washing freshly starved JU1580 isolate, using 5ml autoclaved 
ddH2O per NGM plate, from at least five 60cm plates at room temperature. Collect all virus-
containing liquid and filtrated it with 0.22μm filter unit (Millipore), then mix the clean virus-
containing liquid with a concentrated OP50 food source, in 1:1 ratio. Place 100 adult worms on 
each 60cm NGM plate, which was previously seeded with 1ml mixed virus-OP50 food source. 
Collect the next generation of worms and extract RNAs after infection.    
2.2.Molecular Biology 
 
2.2.1. Plasmid Constructs   
 
         All constructs, Psur-5::rde1::UTR, Psur-5::rde4::UTR, Psur-5::drh-1::UTR, Psur-5::rsd-
2::UTR, Psur-5::rsd-6::UTR and Psur-5::rrf-1::UTR, used for generating transgenic worms were 
driven by constitutive promoter, sur-5; target genes rde-1, rde-4, drh-1, rsd-2, rsd-6 and rrf-1 are 
cloned from wild type worm coding sequence separately by corresponding primers and cloned into 
the constructs by Gibson assembly; 3’ end untranslated (UTR) region was cloned generated from 
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unc-54 sequence.  HIP::FR1gfp::UTR construct is driven by the heat inducible promoter (HIP) 
which is available in our lab already. Myo2::mcherry::UTR and Myo2::gfp::UTR constructs are 
driven by C. elegans pharynx tissue-specific expression promoter Myosin-2, while 
Myo3::mcherry::UTR and Myo3::gfp::UTR constructs are driven by C. elegans body wall muscle-
specific expression promoter Myosin-3. L4440:: mcherry and L4440::gfp constructs were cloned 
base on L4440 vector which used for generating dsRNAs in RNAi feeding experiment.  All 
constructs were confirmed by Sanger sequencing and PCR. Construct plasmids are extracted and 
purified by the Mini Plus Plasmid Extraction kit (Viogene) following its standard protocol. 
2.2.2. Single Worm PCR 
 
           Prepare the worm lysis buffer by combining 2µL of 15mg/ml proteinase K with 100µL 1X 
PCR buffer. Put 6µL of worm lysis buffer in a PCR tube and pick single worm and put the worm 
in the tube. Freeze the tube at -80℃ for 15mins or longer. After that, incubate the tube at 65℃ for 
90mins or longer; inactivate proteinase K by incubating the tube at 95℃ for 15mins. Use 2~3 µL 
the single worm extract for PCR reaction in a total volume of 12ul.  
2.2.3. Reverse Transcription-PCR (RT-PCR)  
 
            10 µL of 2x reverse transcription master mix was prepared by using the random primer 
scheme for initiating cDNA synthesis (Applied biosystems). Random primers ensure that the first 
strand synthesis occurs efficiently with the mRNA present in the reaction mix. Then 10 µL of RNA 
sample (2 µg) was pipetted into the mixture for thermal cycling program: 
Settings Step 1 Step 2 Step 3 Step 4 
Temperature (℃) 25 37 85 4  
Time (min) 10 120 5 ∞ 
 
 
 
26 
2.2.4. Quantitative Real-time PCR (qPCR) 
 
             cDNA generated from step 2.2.3 will be used as a template for quantitative RT-PCR, and 
4ul cDNA of each sample was diluted with water in 25x dilutions. Prepare each reaction mix as 
following, and each reaction was prepared in three replicates: 
 SYBR buffer Forward primer  Backward primer water cDNA dilution 
Volume (µL) 10 1 1 4  4 
 
2.2.5. Sanger Sequencing  
 
        Make a master mix of each sequencing reaction (10 µL) in one tube as following volumes 
(Applied biosystem): 
 BDT 2.5x buffer  Primer (3.3 µM) Template (10ng/ µL) water 
Volume (µL) 0.5 3.5 1 1 4 
Place the tube in a PCR machine run the following thermal cycling program, repeat step1-
step3 for 25 cycles: 
Settings Step 1 Step 2 Step 3 Step 4 
Temperature (℃) 96 50 60 4  
Time (sec) 10 10 240 ∞ 
Once the reaction is finished, add 2.5 µL 125mM EDTA to each reaction tube and mix 
well, then add 30 µL 100% EtOH to each tube and mix well. Incubate the tubes under room 
temperature for at least 15mins, spin reaction mix under 4℃ for 15mins with the maximum speed. 
Remove the supernatant and resuspend sample in 10 µL formamide, vortex well and give the 
samples to technician for sequencing analysis.  
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2.2.6. Fluorescent in-situ Hybridization (FISH) 
 
       Prepare the following solution before the FISH experiment: 
Fixation buffer (10mL): 
1 mL 37% Formaldehyde solution 
1 mL 10x Phosphate Buffered saline, RNase-free 
8 mL Nuclease-free water 
Hybridization buffer (1mL): 
900 µL Stellaris RNA FISH Hybridization buffer (Biosearch Technologies) 
100 µL Deionized Formamide 
Wash Buffer A (10mL): 
2mL Stellaris RNA FISH Wash Buffer A (Biosearch Technologies) 
7mL Nuclease-free water 
1mL Deionized Formamide 
Wash Buffer B (10mL): 
1.2mL Stellaris RNA FISH Wash Buffer A (Biosearch Technologies) 
8.8mL Nuclease-free water 
         Wash worms off by nuclease-free water from NGM plates with E. coli OP50 food or E. coli 
OP50 containing Orsay virus, spin down worms in a 2mL tube and aspirate supernatant, add 1ml 
fixation buffer in the tube and incubate at room temperature for 45mins. After incubation, spin 
down the tube and aspirate supernatant, then wash the worms twice with 1mL of 1x PBS. To 
permeabilize, 70% ethanol was added into the tube and then store at 4℃ overnight. On the other 
day, centrifuge the tube with fixed cells and aspirate supernatant. Add 1mL of prepared wash 
buffer A into the tube and incubate it at room temperature for 5mins. Next remove wash buffer A 
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and dispense 100µL of the Hybridization buffer (Stellaris) that contains 1µL probe into the tube, 
gently mix it with worms and incubate the tube under dark at 37 ℃ for 6 hrs. Add 1mL of wash 
buffer A in the tube and mix well, and then aspirate the supernatant, after that, add 1mL of DAPI 
into the tube, incubate the tube under dark at 37 ℃ for 30 mins. Then aspirate the supernatant in 
the tube and add 1mL pf wash buffer B, incubate the tube at room temperature for 5 mins. Finally, 
add a small drop of medium (Vectashield Mounting) in the tube and mix well with worms. After 
that, the worms are ready for imaging.  
2.2.7. RNA Extraction 
 
            Wash worms off by nuclease-free water from NGM plates with E. coli OP50 food or E. 
coli OP50 containing Orsay virus, collect worms in a 15mL Corning tube. Stand the tube under 
room temperature for 5mins to let the worms sink at the bottom, then aspirate the supernatant. 
Homogenize worms in 1mL Trizol reagent for 1min, after homogenization, add 200 µL chloroform, 
corresponding to the Trizol volume used for initial homogenization in the ratio of 1:5. Shake the 
tube vigorously on the Vortex Mixer for 1min and incubate at room temperature for 3mins for 
phase separation. Transfer the mixture into a 2.0 mL phase-lock tube, RNA will be in the aqueous 
phase after centrifuging at 1500 rpm for 5 mins. Then transfer the aqueous phase from the phase-
lock tube to a new RNase-free 2.0 mL tube, add 0.5 volume of isopropanol. Gently invert several 
times by hand and incubate for 5 mins at room temperature. Centrifuge the tube with the sample 
at 5000 rpm for 15 mins under 4℃, and a white pellet should be visible at the bottom of the tube. 
Carefully discard the supernatant and wash the RNA pellet once by 75% ethanol. Centrifuge the 
tube at 1500 rpm for 3 mins to collect all the liquid in the bottom and discard all the remaining 
ethanol in the tube. Dissolve the RNA pellet by an appropriate amount of DEPC water and measure 
the RNA concentration by Nanodrop equipment. 
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2.2.8. Viral RNA Detection by Northern Blot  
 
       Prepare the following solution before the experiment: 
10x MOPS buffer, pH 7.0 (1 L): 
MOPS                41.85g 
Sodium acetate      10.89g 
EDTA                    0.37g 
H2O                        up to 1L 
20x SSC buffer, pH 7.0 (1 L): 
NaCl                       175.3g 
Sodium Citrate       88.2g 
H2O                        up to 1L 
Denaturing agarose gel (200ml): 
10x MOPS buffer    20ml 
Agarose                   2.4g 
Formaldehyde         5.6ml 
H2O                         up to 200ml 
       Prepare 1.2%(w/v) denaturing agarose gel with formaldehyde, pour the gel in the apparatus 
and wait for solidification. Equilibrate the solidified gel with 1x MOPS in the tray. Mix 6 µg RNA 
samples with an appropriate volume of 5x RNA loading buffer and treated with 65℃ for 10 mins 
and chill samples on ice right after heat treatment. After that, carefully load samples into each well, 
and run the gel at 90V for 2 hrs. Dissemble gel apparatus and transfer the gel on a nylon membrane, 
soaking with 5x SSC buffer, at 70P for 2.5 hrs. Then treat the nylon membrane for 2 mins UV to 
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facilitate RNA-membrane cross-linking. A pre-hybridization membrane in a rolling bottle at 55℃ 
for 30 mins then add prepared probe for overnight slow rotation at 55℃. 
           After overnight incubation, discard the hybridization buffer and wash the membrane with 
Primary washing buffer twice, 15 mins for each time, in a rolling bottle at 55℃; then wash the 
membrane twice with Secondary washing buffer in the rolling bottle, 15 mins for each time, at 
room temperature. After that, place the membrane with RNA side up and apply 0.5 mL CPD-
STAR ready-to-use on the whole membrane, cover the membrane with a plastic sheet and put 
inside a development holder for 1~4 hrs exposure to detect the signal. 
2.2.9. Small RNA Extraction 
 
          Wash worms off by nuclease-free water from 10 large NGM plates with E. coli OP50 food, 
collect worms in a 50mL Corning tube. Stand the tube at room temperature for 15mins to let the 
worms sink at the bottom, then aspirate the supernatant. Homogenize worms in 5mL Trizol reagent 
for 1min, after homogenization, add 1 mL chloroform, corresponding to the Trizol volume used 
for initial homogenization in the ratio of 1:5. Shake the tube vigorously on the Vortex Mixer for 
1min and incubate under room temperature for 3mins for phase separation. Transfer the mixture 
into a 15 mL phase-lock tube, RNA will be in the aqueous phase after centrifuging at 1500 rpm 
for 5 mins. Then transfer the aqueous phase from the phase-lock tube to a new Corning 15 mL 
tube, add 0.5 volume of isopropanol. Gently invert several times by hand and incubate for 5 mins 
at room temperature. Centrifuge the tube with the sample at 5000 rpm for 5 mins at 4℃, and a 
white pellet should be visible at the bottom of the tube. Transfer the aqueous only into another new 
15mL Corning tube, add 0.5 volume of isopropanol, then store it under -20℃ for 48 hrs. After 
cold incubation, centrifuge the tube at 5000 rpm for 20 mins under 4℃, and a white pellet should 
be visible at the bottom of the 15mL tube. Carefully discard the supernatant and wash the RNA 
 
31 
pellet once by 75% ethanol. Spin the tube at 1500 rpm for 3 mins to collect all the liquid in the 
bottom and discard all the remaining ethanol in the tube. Dissolve the RNA pellet by an appropriate 
amount of DEPC treated water and measure the RNA concentration by Nanodrop equipment. 
2.2.10. Preparation of DIG-labeled Probe for Small RNA Detection 
 
         Dilute the designed oligo to 10µM. Mix 2 µL of oligo with 7 µL of DEPC treated water in a 
reaction vial, and mix with the following buffers (DIG-labeling Kit) into the same vial to prepare 
the small RNA detection used probe: 
 Reaction buffer CoCl2-solution  DIG-dUTP dATP solution Terminal transferase 
Volume (µL) 4 4 1 1 1 
Then incubate the tube for 30 mins at 37℃, once incubation is done, add 2 µL of 0.2 M 
EDTA (Ph 8.0) to stop the reaction. Labelled probe tube can be kept -20℃ for long-term storage. 
2.2.11. Small RNA Analysis by Northern Blot 
       Prepare the following solution before the experiment: 
5x TBE buffer (2 L): 
Disodium EDTA        9.38 g 
Trizma Base               108 g 
Borid Acid                  55 g 
H2O                             up to 2 L 
15% Denaturing gel (50 ml): 
5x TBE buffer                                                        10 ml 
Acrylamide: bisacrylamide (19:1, 40%, w/v)        18.75 ml 
Urea                                                                        24 g 
10% (w/v) ammonium persulfate                           500 µL 
TEMED                                                                  25 µL 
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H2O                                                                         up to 50 ml 
            The 10.1 x 7.3 cm2 plates and 1.5 mm spacers with vertical gel system (Bio-Rad Protean 
3) are used for setting 15% denaturing gel. After gel polymerization, put the gel onto the PAGE 
apparatus and apply 0.5x TBE buffer in the system, carefully remove the comb, and then rinse 
excess acrylamide and urea inside the wells with 0.5 x TBE buffer. Ensure all the wells are clean 
and without any small pieces of gel or concentrated urea. Pre-run the gel at 2W for 15 mins. Mix 
5x small RNA gel loading dye with 6 µg small RNA samples and synthesized size markers, 
denature these samples for 5 mins at 95℃ and chill samples on ice right after heat treatment. 
Carefully load samples and size markers into each well and run the gel at 12W for 3hrs or wait 
until the lower dye from the RNA loading dye reaches the bottom of the gel. Dissemble gel 
apparatus and cut the top gel at where 1cm distance the upper dye from the RNA loading dye. 
Soak and shake the upper gel in 0.5 x TBE buffer with ethidium bromide for 15mins and then 
check the equal loading with Nanodrop.  
             Transfer the other half of gel on nylon membrane at 200 mA for 30mins, then treat the 
nylon membrane for 2 mins UV to facilitate RNA-membrane cross-linking. The pre-hybridization 
membrane in a rolling bottle at 37℃ for 15 mins then add prepared probe and size marker probe 
for overnight slow rotation at 37℃. 
            After overnight incubation, discard the hybridization buffer and wash the membrane with 
washing buffer for 2 mins at room temperature. Incubate the membrane in the rolling bottle for 30 
mins in 10 mL Blocking solution, and then discard the solution and incubate it for 30 mins in 10 
mL Antibody Solution. Wash the membrane twice (15 mins each time) with wash buffer, then add 
10 mL Detection buffer for 5 mins. After that, place the membrane with RNA side up and apply 
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0.5 mL CSPD ready-to-use on the whole membrane, cover the membrane with a plastic sheet and 
put inside a development holder for 5 mins exposure to detect the signal. 
            The probe can be removed from the membrane by mixing with 10 mL stripping buffer at 
85 ℃ for 15 mins. Then the same membrane can be re-labelled with different probes by following 
the above hybridization steps. 
2.2.12. Imaging Microscopy 
         Both the red and green fluorescence images were observed and recorded under the same 
exposure strength for each set of images. A Nikon digital camera p7000 mounted on a Nikon 
SMZ1500 microscope was applied to record all the images. The white light background images 
serve as control. 
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Chapter 3. Identification of Novel Genes for Antiviral Immunity in C. elegans 
 
3.1.  Introduction 
 
RNA interference (RNAi) is a natural antiviral mechanism in fungi, plants, and 
invertebrates (Ding and Voinnet, 2007). Antiviral RNAi is triggered by small interfering RNAs 
(siRNAs) derived from viral genome or its replicative intermediates (Ding et al., 2004). 
Mechanistic studies of antiviral RNAi in C. elegans has led to the identification of several critical 
factors involved in this process. RDE-4 is one of the factors required for the biogenesis of virus-
derived siRNAs (Lu et al., 2009b). RDE-4 is a dsRNA binding protein that physically interacts 
with worm dicer DCR-1 and a dicer-like RNA helicase termed DRH-1 (Ermolaeva and 
Schumacher, 2014). DRH-1 was shown to detect viral dsRNA and help dicing complex, formed 
by dicer and RDE-4,  to  move along long dsRNA while unwinding the dsRNA using its helicase 
activity (Coffman et al., 2017; Guo et al., 2013a). It is believed that by unwinding dsRNAs DRH-
1 help expose dsRNA for the capture by RDE-4, which subsequently presents the dsRNA to DCR-
1 for processing. DCR-1 processing of long dsRNA leads to the production of primary siRNAs, 
predominately 23 nucleotides (nt) in size (Guo and lu, 2013; Ketting et al., 2001; Tabara et al., 
2002). One strand of the primary siRNA is loaded into an Argonaut protein termed RDE-1. RDE-
1 is a key component of the RISC complex and has been shown to have slicer activity (Yigit et al., 
2006b). However, RDE-1 slicer activity is only used to remove the passenger strand of the primary 
siRNA (Steiner et al., 2009). The remaining strand of the primary siRNA functions as guide strand 
for the selection of viral transcripts containing complementary sequence. Once selected, the target 
viral transcripts will serve as template for the production of secondary siRNAs. Secondary siRNAs 
are synthesized by an RNA-dependent RNA polymerase, termed RRF-1, in a dicer-independent 
manner. All secondary siRNAs are single-stranded and have a size of 22 nt (Aoki et al., 2007) (Pak 
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and fire, 2007; Sijen et al., 2007). Worm genes rsd-2 and drh-3 are required for the biogenesis of 
secondary siRNAs through currently unknown mechanisms. Unlike primary siRNAs, secondary 
siRNAs carry a triphosphate group, instead of monophosphate group, at the 5’ end (Gent et al., 
2010; Pak and Fire, 2007; Sijen et al., 2007).  
The nematode antiviral RNAi genes drh-1, drh-3 and asd-2 are not conserved in fungi, 
plants or insects (Lu et al., 2009B; Zou et al., 2009). drh-3 and asd-2 products, DRH-3 and RSD-
2, contribute to both antiviral RNAi and classical RNAi (artificial dsRNA triggered RNAi) (Guo 
et al., 2013a; Guo et al., 2013b). Previous work has demonstrated that RSD-2 is dispensable for 
the biogenesis of virus-derived primary siRNAs and promotes the amplification of secondary 
siRNAs (Guo et al., 2013b). The RIG-I-like RNA helicase DRH-1 is required for antiviral RNAi 
but dispensable in classical RNAi. Earlier studies also showed that DRH-1 contributes to Dicer-
dependent antiviral RNAi by acting as a virus sensor and responsible for the production of virus-
derived primary siRNAs. In contrast, DRH-3 acts in a downstream  step and is required for virus-
derived secondary siRNA synthesis (Coffman et al., 2017; Guo et al., 2013a). Currently, the role 
of DRH-3 in antiviral RNAi remains poorly understood.  
In drh-1 null mutants, high-level replication of Orsay virus, a plus-strand RNA virus with 
a bipartite genome, leads to the production of virus-derived siRNAs at low level, as revealed by 
small RNA deep sequencing  (Coffman et al., 2017). This finding explains why classical RNAi 
still remains active in drh-1 null mutants. Presumably, these drh-1-independent siRNAs will be 
loaded into RISC complex to mediate the silencing of viral or host transcripts and the silencing 
effect for host transcripts will be more pronounced since they are produced at a much lower rate 
compared to viral transcripts.  
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Currently how the function of DRH-1 is regulated remains largely unknown. A 
straightforward strategy to address this question would be to identify novel worm genes involved 
in DRH-1 function regulation but dispensable for classical RNAi. Recently Dr. Miska and 
colleagues identified novel worm genes that contribute to antiviral defense in an RNAi-
independent manner, suggesting the existence of RNAi-independent antiviral mechanisms in 
nematode worms  (Le pen et al., 2018; Tanguy et al., 2017). Apparently, identifying novel worm 
genes required for DRH-1 function regulation or RNAi-independent antiviral defenses will 
significantly improve our understanding on worm antiviral innate immunity. Ideally, these novel 
genes should be identified using a replicating virus as a loss of antiviral defense reporter.  
So far, Orsay virus is the only known natural viral pathogen of C. elegans (Félix et al., 
2011b). Orsay virus infects intestine cells and this tissue-specific infection pattern remains 
unchanged in RNAi-defective mutant worms, suggesting that other worm cells may not support 
Orsay virus replication (Jiang et al., 2014b). Since modified Orsay virus genome tagged with 
fluoresce reporter gene was not available we sought to use an alternative model virus as a reporter 
to identify novel antiviral genes in large-scale random genetic screen. 
        The loss-of-antiviral defense reporter used in my study is a flock house virus (FHV) replicon 
termed FR1gfp. FR1gfp is under the control of a heat inducible promoter so viral replication can 
be initiated by shifting the cultivating temperature to a higher degree. In FR1gfp, the gene coding 
for green fluorescence protein (GFP) is used to replace the viral gene encoding the RNAi 
suppressor B2. Therefore, green fluorescence will be observed in worms that are mutagenized to 
lose RNAi-dependent and RNAi-independent antiviral activity. To minimize the chance of picking 
up known antiviral RNAi genes during genetic screen, we introduced 4 known antiviral RNAi 
genes into the reporter worm strain. Since the chance to knock out both endogenous gene and 
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transgene for any of these 4 genes is extreme low, loss of function alleles associated with these 4 
genes will be automatically rejected during screen. Thus, genetic screen utilizing this unique 
reporter worm strain will be biased towards novel genes.  
Upon completing the genetic screen, we isolated 25 genetic alleles in total, which were 
subsequently assigned to rde-3, rrf-1 and 11 unknown genes through genetic complementation 
tests. We found that 9 out of those 11 candidate genes are dispensable for classical RNAi but 
required for antiviral against FR1gfp. Importantly, among those 9 candidate genes with 
dispensable function in classical RNAi, 2 were found to exhibit significant contribution to antiviral 
RNAi against Orsay virus. Considering the fact that Orsay virus specifically infects intestine cells, 
it is likely that these 7 genes may function in non-intestine cells. Since drh-1 gene is the only gene 
important for antiviral RNAi and dispensable for classical RNAi and has been excluded from our 
genetic screen we believe that those 2 candidate genes required for antiviral defense against Orsay 
virus are novel antiviral genes of C. elegans.           
Using mapping-by-sequencing strategy, we identified these two of the candidate genes 
required for both classical RNAi and antiviral RNAi as rsd-6 and mut-16. rsd-6 is known to 
maintain genome integrity whereas mut-16 has been shown to be required for siRNA production. 
However, exactly how these two genes contribute to antiviral defense remains poorly understood. 
Nevertheless, our genetic screen has led to the identification of an antiviral role for these two RNAi 
genes. Mechanistic study of these two genes may allow us to gain novel insight into RNAi-
mediated antiviral innate in worms.  
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3.2. Results 
 
3.2.1.  The Design of a Biased Genetic Screen for the Identification of Novel Antiviral Genes in 
C. elegans 
 
 So far, 10 worm genes have been identified as requirements of antiviral RNAi through 
genetic analyses. These genes include dcr-1, rde-1, rde-2, rde-4, rde-12, drh-1, drh-3, mut-7, rrf-
1, and rsd-2 (Ashe et al., 2013; Guo et al., 2013a; Guo et al., 2013b; Lu et al., 2005; Lu et al., 
2009b; Schott et al., 2005; Shirayama et al., 2014; Wilkins et al., 2005). To ensure that some of 
these genes will not be repeatedly picked up during forward genetic screens we decided to adopt 
a transgene strategy to generate a reporter worm strain that harbors multiple copies of drh-1, rde-
1, rde-4 and rsd-2. Since the chance to simultaneously to knock out both transgene and endogenous 
alleles for these 4 genes will be extremely low a genetic screen utilizing this reporter worm strain 
will miss loss of function alleles associated with these genes. Therefore, our screen efficiency will 
be significantly improved.  
FHV is a member of the Nodaviridae family. Viruses of this family are plus-strand RNA 
viruses with two genome segments, named as RNA1 and RNA2. RNA1 encodes RNA-dependent 
RNA polymerase (RdRP) while RNA 2 encodes virus coat protein. RNA1 is self-sufficient in self-
replication. A subgenomic RNA termed RNA3 is produced during RNA1 replication. RNA3 
translation leads to the production of an RNAi suppressor called B2. FR1gfp is a replicon derived 
from FHV RNA1. In FR1gfp, the B2 coding sequence is replaced by GFP coding sequence (Figure 
3.1. A). This modification renders FR1gfp defective in suppressing antiviral RNAi. However, in 
RNAi-deficient worms FR1gfp can replicate efficiently, leading to the production of green 
fluorescence under UV light. The initiation of FR1gfp replication is under the control of a heat 
inducible promoter, making the initiation of FR1gfp replication as simple as a temperature shift 
(Figure 3.1. B).  These unique features make FR1gfp an ideal viral reporter for the loss of antiviral 
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RNAi (Guo et al., 2012; Guo Lu, 2013; Guo et al., 2013a; Guo et al., 2013b; Lu et al., 2005; Lu et 
al., 2009b; Weinheimer et al., 2015). FR1gfp would also be useful in studying RNAi-independent 
antiviral mechanisms. 
 
Figure 3.1. Schematic of FR1gfp genome structure and the design of biased genetic screen for 
the identification of novel antiviral RNAi genes in C. elegans. (A) FHV contains two 
genomic segments, named as RNA1 and RNA2. RNA1 encodes RNA-dependent-RNA 
polymerase (RdRP) and a sub-genomic RNA3 while RNA 2 encodes virus coat protein. (B) 
FR1gfp is an FHV RNA1 based replicon created by replacing B2 as an eGFP coding 
sequence. FR1gfp transcription is driven by heat inducible promoter. (C) Structure of the 
plasmid constructs used for the reporter transgene array generation. HIP, heat-inducible 
promoter; protein A, viral RdRP; Rz, self-cleaving ribozyme sequence derived from hepatitis 
D virus, which functions to remove all nonviral sequences at the 3’ end of the FR1gfp 
primary transcripts; UTR, the 3’ untranslated region of unc-54 gene (D) The workflow of our 
strategy used for the identification of novel genes with dedicated roles in antiviral RNAi. 
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In C. elegans, gonad injection of foreign DNA at or above a threshold concentration, 
approximately 200ng/µl, often leads to the formation of a large transgene array that can be 
maintained in nuclei and passed on to the next generation (Mello et al., 1991). Since the formation 
of transgene array is not homology-dependent a large transgene array that contains different target 
genes can be easily generated by injecting a mixture of plasmids corresponding to the target genes. 
Based on this observation we decided to develop a reporter worm strain that contains transgenes 
corresponding to several known antiviral RNAi genes. Since the chance to simultaneously mutate 
both transgene allele and endogenous allele of a target gene is extremely low, genetic screens 
utilizing a reporter worm strain that harbors transgenes corresponding to known antiviral RNAi 
genes will automatically reject any loss of function alleles derived from those genes. 
To identify novel worm genes with antiviral activity we decided to perform large-scale 
genetic screen using a unique reporter worm strain that will not pick up loss of function alleles for 
drh-1, rde-1, rde-4 and rsd-2. As shown in Figure 3.1 C and D, we injected FR1gfp;rde-1;rde-4 
worms with a combination of plasmids expressing FR1gfp, drh-1, rde-1, rde-4 and rsd-2 
respectively. All of the four transgenic RNAi genes are under the control of sur-5 promoter, which 
will drive the target gene expression constitutively. FR1gfp serves as a loss-of-function RNAi 
reporter whereas the four transgenic RNAi genes will preclude potential loss of function alleles 
derived from those four RNAi genes.  
3.2.2. Generation of a Reporter Transgene Array for a Biased Genetic Screen 
As illustrated in Figure 3.1 C, FR1gfp expression is under the control of a heat inducible 
promotor, which can be activated at 33℃. Worm head-specific expression of mCherry transgene 
is driven by the myo-2 promoter. To generate a reporter worm strain for large-scale genetic screen, 
we combined all plasmid constructs listed in Figure 3.1 C and injected them into rde-1; rde-4 
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double mutants that contain integrated FR1gfp transgene. 5 transgenic worm lines were then 
picked up after microinjection. Theoretically, successfully microinjection of these six plasmid 
constructs will lead to the formation of large extrachromosomal arrays that contain many copies 
of transgene corresponding to each of the plasmids injected. Accordingly, antiviral RNAi in the 
double mutants containing the transgenic arrays should be restored. As shown in Figure 3.2 A, 
whole body green fluorescence was observed on the double mutant (worms without red 
fluorescence on the head) but not on double mutants  with the transgene arrays (worms with red 
fluorescence on the head), suggesting that both rde-1 and rde-4 transgenes in the transgene arrays 
are functional. Thereafter, one worm line was picked for further gamma-ray irradiation treatment 
and the F2 worms were screened for integrated transgene arrays. In the end 3 transgenic worm 
lines with integrated transgene array were selected for further characterization. All of these 3 
transgenic lines were treated by heat shock and none of them showed green fluorescence, 
suggesting these 3 worm lines all carry functional rde-1 and rde-4 transgenes in the reporter array. 
Among these 3 worm lines, the one free of any development problem was picked for further 
characterization, we named this worm line as ty48.  
3.2.3.  rde-1, rde-4 and FR1gfp Transgenes Are Functional in ty48 Reporter Transgene Array  
 
To find out whether rde-1, rde-4 and FR1gfp transgenes in the reporter transgene array 
ty48 are all functional we introduced ty48 into non-transgenic rde-1;rde-4 double mutants through 
outcrossing, which would have removed the FR1gfp transgene. The resulting worms were then 
checked to see whether they support virus replication. As shown in Figure 3.2 B and C, neither  
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FR1gfp nor Orsay virus can replicate efficiently in rde-1; rde-4 double mutants carrying ty48  
transgene array compared to single or double mutants corresponding to rde-1 and rde-4. 
Consistently, no whole-body green fluoresce was observed in double mutants carrying the ty48 
array (data not shown). To further confirm the restored antiviral RNAi is due to the rde-1 and rde-
4 transgenes in the ty48 transgene array, the mutant worm with ty48 transgene array was fed with 
 
Figure 3.2.  Generation of a reporter transgene array for biased genetic screen and the 
included rde-1 and rde-4 transgenes are functional. (A) Visualization of both non transgenic 
worms (top with red fluorescence selection marker) and transgenic worms 48hrs after heat 
treatment. Single and double mutant of rde-1 and rde-4, and ty48 outcrossed with rde-1; rde-
4 double mutant strains are treated by (B) heat or fed by (C) Orsay virus, the accumulated 
virus replication levels are detected by Northern blot.  rde-1; rde-4 *, the rde-1; rde-4 with 
ty48 transgene array. (D) ty48 is fed by E. coli food expressing no dsRNA(mock), (left)rde-1 
and (right) rde-4 dsRNA and then infected by Orsay virus, the accumulated viral replication 
in ty48 and fed ty48 are detected by Northern blot, indicating antiviral RNAi in ty48 restored 
by functional rde-1 and rde-4. ty48* and ty48**, rde-1; rde-4 with ty48 transgene array is 
fed with rde-1 and rde-4 dsRNA food respectively. (E) ty48 outcrossed with N2 worm and 
then feed by rde-4 dsRNA food, the visualization of green fluorescence of heat-treated worms 
shows FR1gfp is functional in the transgene array. 
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E. coli food expressing either rde-1 or rde-4 dsRNA. As shown in Figure 3.2 D, Orsay virus 
replication level is enhanced in the fed worms, suggesting that the restored antiviral RNAi is indeed 
due to introduced transgene array containing functional rde-1 and rde-4 transgenes. Next, we 
tested if the FR1fgp is functional in the transgene array. We outcrossed ty48 with wild type worm 
to remove the rde-1 and rde-4 loss of function alleles and knocked down RNAi in resulting worms 
through rde-4 dsRNA feeding. We observed whole-body green fluorescence in the treated worms 
after heat treatment (Figure 3.2. E), suggesting that the FR1gfp transgene is functional in the ty48 
transgene array.  
3.2.4. Both drh-1 and rsd-2 Transgenes Are Functional in the ty48 Transgene Array 
 
         In order to determine whether drh-1 and rsd-2 transgenes are successfully integrated into the 
ty48 transgene array, we introduced ty48 into drh-1 and rsd-2 mutants respectively and checked 
viral replication by green fluorescence detection and Northern blot analyses. No green fluoresce 
was observed on either of these single mutants that carries ty48 transgene array after heat induction 
(data not shown). Neither FR1gfp nor Orsay virus genomic RNAs can be detected in the worms 
 
 
Figure 3.3. drh-1 and rsd-2 are successfully integrated into the ty48 transgene array. Northern 
blot to detect (A)FR1gfp and (B) Orsay virus RNAs in wild type worm, drh-1 and rsd-2 
single mutants with ty48 transgene array, single mutant with ty48 but drh-1 or rsd-2 dsRNA 
are knocked down by dsRNA food. N2, wild type worm; drh-1 and rsd-2, drh-1 and rsd-2 
with ty48 transgene array; N2*, drh-1*, N2, drh-1 single mutant fed with drh-1 dsRNA food; 
N2**, rsd-2**, N2, rsd-2 single mutant fed with rsd-2 dsRNA food. 
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(Figure 3.3. A and B), suggesting that antiviral RNAi is restored in both mutants containing the 
ty48 transgene array. Furthermore, when these worm strains were fed with drh-1 (marked as N2*, 
drh-1*) or rsd-2 (marked as N2**, rsd-2**) dsRNA to silence the corresponding genes the 
replication of FR1gfp and Orsay virus were respectively rescued. Taken together, we concluded 
that both drh-1 and rsd-2 transgenes in the ty48 transgene array are functional. 
3.2.5. Antiviral RNAi Remains Defective in drh-3 and rrf-1 Mutants Containing the ty48 
Transgene Array 
 
         It is possible that the antiviral RNAi transgenes in the ty48 array may confer enhanced 
antiviral response and as such the replication of FR1gfp will not be restored in worm mutants in 
which loss of function alleles for novel antiviral genes are created by mutagens. To find out if our 
reporter transgene array ty48 is sensitive enough to pick up genetic alleles with loss of antiviral 
activity in  large-scale genetic screens we transferred the ty48 transgene array into RNAi defective 
mutants corresponding to drh-3 and rrf-1 and viral RNA replication levels were assessed based on 
green fluorescence detection and Northern analyses. 
 
 
Figure 3.4. Antiviral RNAi remains defective in drh-3 and rrf-1 mutants that contains ty48 
transgenes array. (A) FR1gfp replication level detected by Northern blot in N2, drh-3 and rrf-
1 mutants that contains ty48 transgenes array 48hrs after heat shock. (B) Observation of green 
fluorescence drh-3 and rrf-1 mutants that contains ty48 transgenes array 48hrs after heat 
shock. (C) Orsay virus RNAs replication level detected by Northern blot in N2, drh-3 and rrf-
1 mutants that contains ty48 transgenes array. 
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         Both of drh-3 and rrf-1 are required for worm secondary siRNA synthesis (Ketting et al., 
2001; Sijen et al., 2001; Steiner et al., 2009; Tabara et al., 1999; Tabara et al., 2002) and, from our 
previous work, viral RNAs accumulated to a higher level in drh-3 mutant than in rrf-1 mutant 
(Guo et al., 2013a). We found RNAi is still defective in drh-3 and rrf-1 mutants that carry the ty48 
transgene array (Figure 3.4. A, B and C). Consist with our previous finding, the green fluorescence 
intensity, FR1gfp and Orsay virus accumulation level are higher in drh-3 mutants compared to  
rrf-1 mutants carrying the same ty48 transgene array. These findings together suggest the ty48 
transgene array dos not compensate the loss of antiviral activity caused by mutations in other 
antiviral genes, making it a robust reporter for the identification of novel antiviral genes through 
large-scale genetic screen. Moreover, FR1gfp replicons are not able to move between cells, this 
transgene reporter used in the genetic screen will lead us to find the novel antiviral RNAi genes in 
a cell-autonomous manner. 
3.2.6. Identification of Novel Antiviral RNAi Genes through Large-scale Genetic Screen 
 
         After being successfully characterized the ty48 transgene array was used as loss of antiviral 
activity reporter in a large-scale genetic screen carried out in our lab. As illustrated in Figure 3.5. 
A, young adult worms were collected and treated by chemical mutagen, ethyl methanesulfonate 
(EMS). EMS introduces whole-genome wide random mutations, making all the genes have equal 
chance to be mutated under the treatment. Then the adult F1 worms were bleached to reduce allele 
duplicates in the F2 generation. By Mendelian inheritance, homozygous 
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alleles can be picked up during genetic screen by checking green fluorescence 48 hrs after heat 
induction. Therefore, only the worms show the green fluorescence no weaker than rrf-1 mutants 
with same transgene array (Figure 3.4. B, top worms) were picked up for further confirmation.  
 
Figure 3.5. Experimental design of the larger-scale genetic screen. (A)Young adult N2 worm 
with ty48 transgene reporter are treated by EMS, F1 eggs were collected by bleach when 
treated N2 grow as fully developed adults with eggs. Heat shock F2 worms at 33 ℃ for 3hrs 
and then maintained in 25℃ incubator for 48 hrs, picking up all the worms show green 
fluorescence no weaker than rrf-1 single mutants with same transgene array, and main each 
candidate in separate plates. (B) Schematic of genetic complementation test. Check pairwise-
crossed F1s green fluorescence after heat treatment, if mutations belong to the same gene but 
different alleles, RNAi cannot be restored which means heterozygous F1 show green 
fluorescence; otherwise, RNAi will be restored by parents carry mutation on different genes, 
and no green florescence should be observed on F1. 
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25 mutant alleles were picked up from the large-scale genetic screen, and all of them are 
recessive mutant alleles as confirmed by outcrossing with wild type N2 worms. We found that 
mutant worms carrying the 1026f, 1027e, 1103a, or 1026g alleles failed to propagate at 25℃, 
suggesting these alleles are temperature-sensitive alleles. At room temperature, worms carrying 
the 1026f, 1027e, 1103a, 1026g, 1026a, 1031a, 1031f or 1105a exhibited reduced brood sizes. 
Worms carrying 1030c allele produced large amount of dead eggs and males (Table 1). These 
observations suggest that some of the identified genes play an essential role in worm development. 
Through genetic complementation test, as illustrated in Figure 3.5. B, we assigned the mutant 
alleles to 13 candidate genes. We named these candidate genes as antiviral silencing-defective (asd) 
genes. Interestingly, we found that all the temperature-sensitive alleles were assigned to same 
candidate gene asd-1 and different alleles of the same candidate gene usually exhibited the same 
developmental phenotype (please refer to asd-2, asd-3, asd-4 and asd-5 in Table 1). 
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To find out whether any of our candidate alleles belong to known antiviral RNAi genes such as 
dcr-1, rde-1, rde-2, rde-4, rde-12, drh-1, drh-3, mut-7, rrf-1, and rsd-2, extensive genetic 
complementation tests were performed between each of our candidate alleles and loss of function 
allele corresponding to each of the known antiviral RNAi genes. From these tests we identified 
asd-6 as rde-3 and asd-13 as rrf-1. This finding was further confirmed by cDNA sequencing 
(Figure 3.6. A and B) and function restoration assay (Figure 3.6. C). A G-to-A missense mutation 
at position 540 of rrf-1 gene, which leads to an alteration of glycine to aspartic acid, was identified 
in 1025a whereas A C-to-T nonsense mutation after the first 96 codons of rrf-1 gene, which causes 
a premature stop codon, was identified in 1026e. A G-to-A nonsense mutation in rde-3 gene, which 
 
Figure 3.6. asd-6 is identified as rde-3 and asd-13 as rrf-1. (A) cDNA sequencing of rrf-1 
coding sequence in candidate alleles 1025a and 1026e. (B) rde-3 coding sequence in allele 
1031b. All mutations are RNAi defective. (C) Plasmid construct containing wild type rde-3 is 
driven by Psur-5 promoter and used for microinjection in 1031b worms (upper). Successfully 
injected worms carry red fluorescence on the head and show no green fluorescence after heat 
induction, compared with RNAi defective 1031b worm. 
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results in a C-terminal 350amino acids (aa) deletion in RDE-3 was identified for 1031b. Nonsense 
mutations in both 1026e and 1031b resulted in non-functional protein, presumptively leading to 
the loss of antiviral RNAi. After injecting plasmid expressing wildtype rde-3 coding sequence into 
1031b worms we observed the restoration of antiviral RNAi in the injected worms (Figure 3.6. C). 
In addition to rrf-1, multiple alleles isolated from different batches of mutagenized worms were 
assigned to asd-1, asd-2, asd-3, asd-4 and asd5 respectively. Noticeably, none of these candidate 
alleles are derived from rde-1, rde-4, drh-1 or rsd-2, suggest that, as we expected, our biased 
genetic screen automatically rejected alleles derived from these genes. 
3.2.7. Functional Characterization of the Identified Candidate Genes 
 
          The major aim of my study is to identify novel antiviral genes that are not in the classical 
RNAi pathway. To find out whether any of our candidate genes contribute to antiviral immunity 
in an RNAi-independent manner we performed outcrosses to deliver our candidate alleles into 
LR11 worms (Figure 3.7. A). LR11 worms contain a transgene array harboring both FR1gfp and 
mCherry transgenes. Upon finishing the crosses homozygous asd alleles were confirmed by 
checking the production of green fluorescence after heat induction (Figure 3.7. A upper). FR1gfp 
serves as the loss of antiviral immunity reporter whereas the body wall-expressing mCherry, driven 
by the myo-3 promoter (Figure 3.7. A lower), can be targeted for silencing through mCherry 
dsRNA feeding. We included drh-1 and rde-4 as controls in this test as drh-1 gene is specifically 
required for antiviral RNAi but not classical RNAi whereas rde-4 is required for both (Guo et al., 
2013a; Guo et al., 2013b). Heat induction tests suggest that all asd alleles in LR11 worms are 
antiviral defective (Figure 3.7. B and C). However, we found that asd-1, asd-5, asd-6 (rde-3)  
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Figure 3.7. Functional identification of asd candidate genes. (A) Experimental design of 
outcross between asd candidates with a worm strain, LR11, which carries linked FR1gfp 
and myo3mcherry transgenes. m, loss-of-function alleles identified in the biased genetic 
screen; Pmyo-3, myo-3 promoter actives in worm body wall muscle. (B) Northern blot 
detection of FR1gfp replication in LR 11 worms that carry genetic alleles, required for both 
classical RNAi and antiviral RNAi. (C) Northern blot detection of FR1gfp replication in LR 
11 worms with dedicated antiviral RNAi alleles. (D) Visualization of red fluorescence of all 
asd candidates fed with E.coli food containing mcherry coding sequence dsRNA. Main 
images were taken without light, inserted images taken under white light. (E) and (F) 
records the worm phenotypes after injected with unc-22 dsRNA at a 100 ng/µl. Bar graphs 
show the percentage of the twitching F1 progenies generated from the injected worms, 
collected between 8 to 12 hrs post-injection. 
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mutants remain resistant to mCherry dsRNA ingestion as rde-4 null mutants do. Like drh-1 worms, 
the rest of asd mutants were all sensitive to mCherry dsRNA feeding, exhibiting strong silencing 
in body wall muscle (Figure 3.7. D). This result suggests that 9 of our asd genes (asd-2, asd-3, 
asd-4, asd-7, asd-8, asd-9, asd-10, asd-11, and asd-12) do not play important role in classical 
RNAi. As a reconfirmation, we repeated feeding RNAi test using worm endogenous genes skn-1 
and unc-22 as targets of feeding RNAi. Silencing of unc-22 and skn-1 genes leads to severe 
twitching and dead eggs phenotypes respectively in wild type worms. Feeding RNAi phenotypes 
for our asd candidates were recorded after feeding with E.coli food containing unc-22 or skn-1 
dsRNAs. I found the same 9 asd candidates, asd-2, asd-3, asd-4, asd-7, asd-8, asd-9, asd-10, asd-
11, and asd-12, are sensitive to dsRNAs feeding targeting either unc-22 or skn-1 (Table 2). To rule 
out the possibility that the observed RNAi phenotypes are artifacts associated with dsRNA feeding, 
we injected unc-22 dsRNAs into the same set worms and found that twitching phenotypes in the 
progenies remain the same as dsRNA feeding (Figure 3.7. E and F). Taken together, these findings 
suggest that 9 out of the 11 asd genes contribute to antiviral immunity in an RNAi-independent 
manner.  
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3.2.8. Identification of asd-1 as mut-16, and asd-5 as rsd-6 through Whole-genome Sequencing 
 
Mapping-by-sequencing strategy was performed to identify asd-1 and asd-5, which 
contribute to both antiviral RNAi and classical RNAi. F2 bulk segregant analysis (Doitsidou et al., 
2010; Sarin et al., 2008) was conducted by outcrossing asd-1 or asd-5 worms with wild type N2 
worms. 50 F2 progenies with target mutation (showed bright green fluorescence after heat 
induction) 50 F2 worms without target mutation (showed no green fluorescence after heat 
induction) were picked up (Figure 3.8.) to prepare mutant pool and wild type pool respectively. 
The F3 progenies were then pooled, sequenced, and analyzed using in-house-developed workflow 
(Long et al., 2018). Eventually asd-1 allele was mapped to B0379.3 on chromosome I, which  
encodes MUT-16 and asd-5 allele were mapped to F16D3.2 on the same chromosome, which 
encodes RSD-6.      
        When Sanger sequencing was carried out to check mut-16 coding sequence in all asd-1 alleles 
we found a G-to-A nonsense mutation at position 1635nt in 1027e allele, a C-to-T nonsense 
mutation at position 2215nt in 1026f allele, a C-to-T non-sense mutation  at position 2215nt in 
1026g allele and a C-to-T nonsense mutation at position 2459nt in 1103a. These mutations, except 
the one in 1027e, caused large deletions at the C terminal of MUT-16 protein (Figure 3.9. A, left). 
In asd-5 mutants, we identified a C-to-T nonsense mutation at position 430nt in 1026a allele, a C- 
to-T nonsense mutation at position 290nt in 1031a allele and a G-to-A nonsense mutation at 
position 157nt in 1031f allele. All of these mutations caused very large deletions, which should 
have rendered the mutant RSD-6 protein completely non-functional (Figure 3.9.A, right). 
           We found that F2 worms generated from genetic complementation either between known 
mut-16 mutants with asd-1 worms were still defective in antiviral RNAi, further confirming that  
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asd-1 is indeed mut-16 (Figure 3.9. B). When wild type worms carrying ty48 transgene array were 
fed with E. coli food containing mut-16 or rsd-6 dsRNA, as shown in Figure 3.9 C, enhanced viral 
replication was observed for both FR1gfp and Orsay virus. Microinjection of plasmid 
constitutively expressing wild type MUT-16 or RSD-6 (Figure 3.9. D) into corresponding mutants 
with ty48 transgene was found to restore antiviral viral RNAi in asd-5 worms but not in asd-1 
worms (Figure 3.9. E and F). 
Figure 3.8. Schematic of mapping-by-sequencing strategy. Specific allele picked from either 
asd-1 or asd-5 were crossed with wild type worms. 50 F2 progenies with loss of antiviral 
RNAi phenotype (showed green fluorescence after heat induction) and with restored 
antiviral RNAi (no green fluorescence after heat induction) were picked up, F3 progenies 
were collected, pooled, analyzed. Random mutations were removed by subtraction of 
mutations between both pools. Green stars, random mutation; red star, genetic mutation 
caused by EMS.  
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Both MUT-16 and RSD-6 have not been shown to function in antiviral RNAi. Previously 
MUT-16 is found as a worm-specific protein that plays important function in secondary siRNA, 
WAGO 22G RNA, pathway in both somatic and germline RNAi (Phillips et al., 2012). RSD-6 is 
 
Figure 3.9. Identification of asd-1 as mut-16, and asd-5 as asd-6. (A) Schematic of Sanger 
sequencing results of 1027e, 1026f, 1026g and 1103a alleles compared with wild type mut-16 
coding sequence, while 1026a, 1031a and 1031f alleles compared with wild type rsd-6 coding 
sequence. (B) Experimental design of genetic complementation to confirm asd-1(1027e allele) 
is mut-16. mut-16 null allele is NL1800 or JK3826 strain that with ty48 transgene reporter. F1 
progenies generated from cross all showed green fluorescence at 48hr after heat induction. (C) 
Northern blot detection of FR1gfp replicon and Orsay RNA accumulation level 48hr after heat 
induction. L4440, N2 worms that feed with E. coli food contains vector only; mut-16 RNAi, 
N2 worms that feed with E. coli food containing mut-16 dsRNA; drh-1, N2 worms that feed 
with E. coli food containing drh-1 dsRNA; 1027e, asd-1 allele feeds with normal E. coli food. 
(D) Constitutively expressed MUT-16 and RSD-6 plasmid constructs. (E) Visualization of 
48hrs post-heat-induced worms: rsd-6 mutant, top; 1026a with red fluorescence as selection 
marker, which carries injected wild type rsd-6, middle; 1027e allele, bottom. (F) Northern blot 
of FR1gfp replicon and Orsay virus RNA replication level from (E) resulted in worms. 
1026a*, 1026a allele that carries injected wild type rsd-6 coding sequence. 
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known to be engaged in an endogenous gene-silencing pathway that helps maintaining genome 
integrity under unfavorable conditions (Phillips et al., 2012; Sakaguchi et al., 2014). Thus, my 
study is the first to confirm that both of MUT-16 and RSD-6 are essential for antiviral RNAi and 
classical RNAi. My findings also suggest that, in nematode worms, there is an interplay between 
antiviral innate immunity and the mechanism that maintains genome integrity. 
 
3.2.9. asd-2 and asd-9 Are Required for RNAi Targeting the Orsay Virus 
 
In order to determine whether any of our asd genes are required for antiviral defense 
against Orsay virus, all asd worms that carry either ty48 transgene (Figure 3.10. A) or LR11 
transgene (Figure 3.10. A) were challenged by Orsay virus. High-level Orsay virus replication 
were detected in asd-1 (mut-16), asd-5 (rsd-6) and asd-6 (rde-3) worms, which are defective in 
classical RNAi and antiviral RNAi, but not in asd-3, asd-4, asd-7, asd-8, asd-10, asd-11 or asd-
12 worms. However, we observed significantly enhanced Orsay virus replication in asd-2 and 
asd-9 worms.  
 
Figure 3.10. asd-2 and asd-9 are required for antiviral RNAi in targeting the Orsay virus. 
Orsay virus replication detected among asd alleles with (A) LR11 transgene reporter and (B) 
ty48 transgene reporter respectively. (C) Cell localization of Orsay viral mRNA by FISH in 
N2, asd-2 and asd-9 worms that infected by the Orsay virus. 
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             Since the Orsay virus specifically infects intestine cells, fluorescence in situ hybridization 
assay (FISH) was carried out to detect the Orsay virus infection pattern in all of the 9 asd candidate 
genes that do not contribute to classical RNAi. As expected, viral infection manifested as red 
fluorescence was detected in intestine cells in both asd-2 and asd-9 worms (Figure 3.10. C). Orsay 
virus infection can be barely detected for the rest of asd candidates and N2 worms. These findings 
together with the results shown from Figure 3.7 suggest that asd-2 and asd-9 play essential role in 
antiviral defense but are dispensable for classical RNAi.  
3.2.10. asd-9 and asd-5 (rsd-6) Are Required for the Biogenesis or Stability of Primary Viral 
siRNAs 
 
To define the roles for asd-2, asd-9 and rsd-6 in antiviral defense, I conducted Northern 
blot analyses to detect the accumulation level of virus-derived siRNAs (vsiRNAs) in 
corresponding mutants. rde-4, drh-1, and rde-1 mutants with the same LR 11 transgene were 
included in the test as controls since vsiRNA accumulation in these mutants has been well 
characterized. As shown in Figure 3.11 A, FR1gfp genomic and subgenomic RNAs accumulated 
to comparable levels in all mutant worms. However, in contrast, vsiRNA accumulations are 
significantly different among these mutants. In C. elegans, primary vsiRNAs are mainly 23nt while 
secondary vsiRNAs are dominantly 22nt with tri-phosphate group at the 5’ end. Consistent with 
our previous findings, I detected high-level vsiRNA in worms carry rde-1 alleles and low level in 
rde-4 and drh-1 mutants. I found that primary vsiRNAs in asd-9 and rsd-6 mutants accumulated 
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to the same level as that in drh-1 mutants. Interestingly, however, asd-2 mutants accumulated high-
level vsiRNAs like that detected in rde-1 mutants (Figure 3.11. B), suggesting that asd-9 and rsd-
6, but not asd-2, are required for the synthesis of primary vsiRNAs.   
To find out in which step rsd-6 contributes to antiviral RNAi, I created double mutants 
corresponding to rsd-6; rde-4, rsd-6; drh-1, and rsd-6; rde-1 and checked vsiRNA accumulation 
in the double mutants. I observed increased viral replication in rde-1; rsd-6 compared to the single 
mutants. However, such an increase was not observed in rsd-6; rde-4 or rsd-6;drh-1 double 
mutants (Figure 3.11. C). Noticeably, vsiRNAs accumulated to a lower level in rsd-6; rde-4 and 
 
 
Figure 3.11. asd-9 and rsd-6, but not asd-2, are required for biogenesis or stability of primary 
viral siRNAs. (A) Detection of FR1gfp viral RNAs by northern blot in asd-2(1029e), asd-
9(1026d), and rsd-6(1026a) 48hr after heat induction. N2, drh-1, rde-1 and rde-4 mutants 
included as references. (B) Small RNA detection of vsiRNAs generated from alleles in (A). 
(C) Detection of FR1gfp viral RNAs in rde-4/rsd-6, drh-1/rsd-6 and rde-1/rsd-6 double 
mutants, corresponding single mutants included as references. (D) Detection of vsiRNAs in 
mutants shown in (C). miR-58 accumulation in all mutants was detected and used as equal 
loading control. 
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rsd-6;drh-1 double mutants as compared to single mutants. Interestingly, vsiRNA accumulation 
in rsd-6; rde-1 double mutants remained mor or less the same as that in rde-1 single mutants 
(Figure 3.11. D). Taken together, these results suggest that RSD-6 may contribute to the biogenesis 
or stability of vsiRNAs in a separate pathway. 
3.3. Conclusion 
 
The short life span and hermaphroditic lifestyle make C. elegans a powerful system for 
gene identification through the forward genetic screen. However, the large-scale forward genetic 
screen in the C. elegans system is still a time-consuming and labor-intensive process, mainly 
because many of the target genes are repeatedly picked up during the screen, and consequently, 
much effort will be wasted in characterizing the redundant alleles. By introducing extra copies of 
known antiviral RNAi genes into the reporter worm strain, we were able to successfully reject 
alleles corresponding to those genes during the genetic screen. Since co-delivery of multiple 
transgenes into C. elegans through gonad microinjection can be done in laboratories with basic 
microinjection facilities, this strategy can be easily adopted for identification of novel genes 
involved in other biological pathways. The small body size and short life cycle of C. elegans 
suggest that gene discovery in the C. elegans system can be easily scaled up to screen a very large 
number of mutagenized worms, even in laboratories with limited resources. Thus, our approach 
combined with a mapping-by-sequencing strategy will allow for rapid identification of 
functionally redundant genes and genes with low mutation rates. 
In this chapter, we designed a biased genetic screen strategy by chemical mutagenesis to 
identify novel genes with dedicated function in worm antiviral RNAi. First, we developed a 
reporter worm strain that carries extra copies of 4 known antiviral RNAi genes (rde-1, rde-4, drh-
1 and rsd-2) and a FR1gfp viral replicon as a reporter for the loss of RNAi activity. The 4 known 
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genes helped to automatically reject picking up alleles derived from these known genes. Upon the 
genetic screen, we isolated 25 viable mutants that exhibited enhanced green fluorescence than rrf-
1 mutant. Through genetic complementation test, we assigned them into 11 candidate genes and 
two known RNAi genes. Of the 11 candidate genes, 9 candidate genes were found to be 
dispensable in classical RNAi. Importantly, we found that, among the 9 candidate genes, asd-2 
and asd-9 are required for antiviral RNAi targeting Orsay virus but appear dispensable for classical 
RNAi. Since the design of our screen strategy has already excluded drh-1 as a target of our genetic 
screen, which is also confirmed by sequencing of drh-1 coding sequence for our candidates, we 
believe asd-2 and asd-9 are novel antiviral RNAi genes. Mechanistic study of these two genes may 
allow us to gain further insight into the mechanisms by which viruses are detected and destroyed 
by the RNAi machinery in C. elegans.  
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Chapter 4. Identification of Novel Host Factors Required for Virus Genome 
Replication 
 
4.1. Introduction 
 
Viruses are obligate intracellular parasites that can only reproduce themselves within living 
organisms. In animal cells, viral particles can multiply hundreds of folds within a short viral 
replication cycle, which can be accomplished from a couple of hours to at most a few days. In the 
Baltimore classification system, there are 7 different classes of viruses that are grouped based on 
the constitution (DNA or RNA) and replication strategy of their genomes and the way their 
mRNAs are produced. They are double stranded DNA (dsDNA) viruses (Class I), single-stranded 
DNA (ssDNA) viruses (Class II), double-stranded RNA (dsRNA) viruses (Class III), plus-stranded 
RNA (+ssRNA) viruses (Class IV), minus-stranded RNA (-ssRNA) viruses (Class V), Class VI. 
A typical virus replication cycle involves attaching to and penetrating host cells, uncoating 
the viral nucleic acid genome, replicating the virus genome, synthesizing virus protein, assembling 
components, and egressing new viruses via budding or cell lysis (Figure 4.1.). The process of virus 
genome replication is catalyzed by both host and viral enzymes, the relative contribution of which 
differs between the types of DNA or RNA viruses. Viruses with DNA genomes utilize host 
encoded RNA Polymerase II to transcribe their genomes in the nucleus of host cells, with exception 
of poxviruses, which replicate in the cytoplasm of host cells and gain the help from novel 
transcriptase. Viruses with RNA genome utilize virus-encoded RNA-dependent RNA polymerase 
to synthesize their genomes in the cytoplasm of host cells, with exception of retroviruses, which 
take two steps to replicate their genomes: in the cytoplasm the genome is transcribed into DNA 
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whereas in the nucleus the genome is converted into RNA using host-encoded DNA-dependent 
RNA polymerase.  
To minimize the burden of virus genome length and to maximize the rate of synthesized 
virus proteins, some viral mRNAs can code more than one protein. Virus protein synthesis is 
 
Figure 4.1. Schematic of +ssRNA virus infection cycle. +ssRNA viruses enter host cells by 
either endocytosis (animal cells) or wounds (plant cells). After entrance and uncoating, 
viruses genomic RNAs are released in the cytoplasm where they are translated into viral 
replication complex (VRC) proteins by exploiting host cell ribosomes, VRC then synthesizes 
the complementary -RNAs, which functions as the template for synthesis of numerous 
+ssRNAs. The new +ssRNAs are new templates for the next cycle of replication and 
translation, or undergo encapsidation and coating and then egress animal cells or move 
between plant cells. 
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thoroughly dependent on host cell translation machinery. Since the structure of virus mRNAs are 
similar to host mRNAs, viral mRNAs can serve as translation templates and exploit host translation 
factors in competing or suppressing host own translation process.  
Among these 7 different virus classes, class IV viruses constitute the largest group of 
known viruses. Approximately 70% of plant viruses are +ssRNA viruses. Meanwhile a variety of 
mammalian +ssRNA viruses, such as COVID-19, SARS, hepacivirus C, West Nile virus, and 
dengue virus, represent big threat to human health. +ssRNA viruses have compelling infection 
advantage over minus-stranded RNA (-ssRNA) viruses and DNA viruses because their genomes 
can function as both genomes and mRNAs (Dreher and Miller, 2006; Simon and Miller, 2013). 
Flock house virus (FHV) is such as a class IV virus that contains two RNA genomic segments, 
RNA1 and RNA2. FHV genomic RNAs are released right after entry into host cells and act as 
translation template to produce replicase, an RNA-dependent-RNA polymerase (RdRP), which is 
encoded by RNA1, sub-genomic RNA3 and virus coat protein, encoded by RNA2. RdRP recruits 
cell factors to produce a complementary -ssRNA using original RNA1 as a template, then the -
ssRNA is going to function as a new template, and undergo additional rounds of replication and 
translation steps, to produce numerous +ssRNAs that are identical to original RNA1 segment. 
RNA1 replicon can self-replicate without RNA2. RNA3 encodes RNAi suppressor B2 which 
inhibits RNAi-mediated antiviral immune response (Figure 3.1. A).   
To counteract o virus infection, cellular hosts have evolved innate immune mechanism and 
adaptive immune response to inactivate or eliminate viruses. RNA interference (RNAi) is an 
ancient and conserved innate immune antiviral system in defending against RNA virus infection. 
The RNAi phenomenon was first reported in the model organism Caenorhabditis elegans, which 
share many conserved homologous genes with humans. C. elegans is an ideal model to study host-
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virus interactions because of its short life cycle, transparent body, well-studied gene bank and lack 
of adaptive immune system. To date, both an FHV replicon, termed FR1gfp, and a natural viral 
pathogen of C. elegans, the Orsay virus, are used as model virus to study many aspects of virus-
host interaction in nematode worms (Ashe et al., 2013; Lu et al., 2009a). Both viruses are plus-
stranded RNA (+ssRNA) viruses in Class IV of Baltimore classification system, making C. elegans 
a great genetic model system for the study of virus-host interaction and the identification of host 
factors required for +ssRNA virus replication. 
           A complete +ssRNA virus replication cycle can exploit a significant fraction of 20,000-
30,000 host proteins (Nagy and Pogany, 2006). Identification of host molecules participating in 
each step of virus replication could provide valuable new targets for antiviral therapy. 
Theoretically, disrupting the interaction between viral products and host factors required for viral 
replication could significantly inhibit viral replication, leaving host immune systems enough time 
to target and destroy invading virus. Drugs targeting host factors are advantageous over drugs 
targeting viral factors in that their antiviral activity will not be compromised by genetic mutations 
in viral genome. Since some host factors are used for replication by different viruses of this same 
family or viruses from different families drugs targeting common host factors may confer wide-
spectrum antiviral activities. Identifying host factors involved in virus replication through RNAi-
based genetic screening in mammalian cell cultures has been unsuccessful. Although genetic 
screens in yeast system have successfully identified some genes required for RNA virus 
replication, those findings may not contribute much to the identification of human genes involved 
in virus replication considering the genetic distance between yeast and humans (Nawaz-ul-Rehman 
et al., 2013; Panavas et al., 2005).  
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So far, three worm genes, sid-3, viro-2 and drl-1, have been identified as key host factors 
required for Orsay virus replication. However, all of those factors may act in the early pre-
replication step of virus life cycle (Coffman et al., 2017; Sandoval et al., 2019). The fact that viral 
replication initiated from Orsay virus transgenes is not affected by mutations in sid-3, viro-2 or 
drl-1 suggests that these three genes play a role in Orsay virus cell entry. Since viruses often use 
distinct host factors to gain cell entry antiviral drugs targeting products of these three genes may 
not confer wide-spectrum antiviral activities. So far, no worm gene has been identified as key 
contributor of viral genome replication.  
The FR1gfp replicon can initiate self-replication efficiently in C. elegans mutants defective 
in antiviral RNAi. Since FR1gfp is introduced into C. elegans as a transgene it bypasses the cell 
entry step, which is normally required for a real virus to initiate infection. FR1gfp replication does 
not lead to the production viral particles. Instead, only two proteins will be produced, with one 
directing viral genome replication and other producing green fluorescence. These features make 
FR1gfp an ideal reporter for the identification of worm genes involved in FHV genome replication 
in genome-wide genetic screens. Since many +ssRNA viruses share the same set of host factors 
for genome replication some of the genes required for FR1gfp genome replication may also play 
important role in directing genome replication for many other +ssRNA viruses, such as Orsay 
virus. To improve the sensitivity and robustness of this reporter system I used a triple worm mutant 
containing the FR1gfp replicon as a readout of loss of viral genome replication. Following 
chemical mutagenesis, 16 candidate mutants were picked up that showed significantly reduced 
viral replication. Through genetic complementation, these 16 alleles were assigned to 12 candidate 
genes. Importantly, I found some of these candidate genes are also required for the infection by 
Orsay virus. I found that Orsay virus replication initiated from a transgene still requires those 
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candidate genes. Since viral replication initiated from transgenes bypasses the cell entry step it 
thus can be concluded that those candidate genes required for Orsay virus infection are actually 
key host genes contributing to Orsay virus genome replication. To my knowledge, this is the first 
work to identify novel factors required for Orsay virus genome replication in nematode worms. 
+ssRNA viruses, such as SARS coronavirus, COVID-19 virus, zika virus and West Nile 
virus, still represent major global health threats to human beings. Functional and mechanistic study 
of my candidate genes may lead to the development of novel antiviral drugs with broad-spectrum 
antiviral activities against those formidable human viral pathogens.  
4.2. Results 
 
4.2.1. Development of a Reporter Worm Strain Defective in Antiviral RNAi 
 
4.2.1.1. Generation of the Reporter Worm Strain through Genetic Crosses 
 
To identify novel host factors essential for +ssRNA virus infection in C. elegans, an RNAi 
defective worm strain was generated by genetic cross, which carries a loss of RNAi reporter 
FR1gfp. My previous work showed that FR1gfp is a robust and sensitive reporter for loss of 
antiviral defense (described in Chapter 3). LR11 is an N2 transgenic line carrying an FR1gfp 
transgene, termed 11, which is physically linked to an mCherry reporter transgene. The mCherry 
transgene directs strong mCherry expression in body wall muscle and can be easily silenced 
through feeding or injection of artificial mCherry dsRNA (Long et al., 2018). Through genetic 
crosses the FR1gfp transgene array was introduced into RNAi defective mutants corresponding to 
drh-1, rde-1, and rde-4 and the resulting worm strains were named 11; drh-1, 11;rde-1, and 11;rde-
4 respectively. Heat induction combined with green fluorescence detection and northern blot 
analyses suggested that FR1gfp replication is significantly enhanced in these single mutants.  
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DRH-1, RDE-1 and RDE-4 are the critical components of worm antiviral RNAi pathway. 
Among these 3 antiviral factors DRH-1 acts as a detector of viral dsRNA, presumably the 
replication intermediates, facilitating Dicer-dependent siRNA biogenesis (Ashe et al., 2013; Guo 
et al., 2013a; Lu et al., 2009a). RDE-1 is a member of the RISC  complex responsible for silencing 
cognate viral RNA transcripts (Tabara et al., 1999; Yigit et al., 2006a). RDE-4 is a dsRNA binding 
protein which interacts with and passes dsRNA to Dicer (Guo et al., 2013b; Lu et al., 2005; Tabara 
et al., 2002).  Although both DRH-1 and RDE-4 contribute to viral siRNA biogenesis their 
functional role in this regard appear different. Whereas RDE-4 is important for the biogenesis of 
siRNA derived from the terminal regions of viral genome DRH-1 seems to be responsible for the 
production of viral siRNAs from the middle region of viral genome (Coffman et al., 2017).  
Considering its potential RNA helicase activity DRH-1 may help unwind viral dsRNA to remove 
viral proteins that bind and protect viral dsRNA from Dicer processing.  Consistent with hypothesis 
we found that viral replication in drh-1;rde-4 double mutants is further enhanced compared to the 
single mutants (Guo et al., 2013b). Previously, it has been shown that C04F12.1 contributes to an 
rde-1-independent antiviral RNAi. C04F12.1 encodes anther Argonaut protein closely related to 
RDE-1. These observations together suggest that antiviral RNAi cannot be completely abolished 
in single mutants corresponding to any one of these 3 genes. Conceivably, if one of the single 
mutants is used in large-scale genetic screens to look for worm genes required for viral genome 
replication, weak alleles that only partially compromised viral genome replication will very likely 
be missed during the screen process. Most importantly, there is an endogenous RNAi pathway that 
appears to compete with antiviral RNAi pathway for key factors (Yigit et al., 2006a). As a result, 
the antiviral RNAi activity can be further enhanced in worm mutants defective in this endogenous 
RNAi pathway (Lu et al., 2009a). It is thus likely that random mutations that disrupt endogenous 
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RNAi pathway will boost the residual antiviral RNAi activity and inhibit viral replication in single 
mutants, leading to isolation of false positive mutants. In order to significantly improve our gene 
discovery efficiency, I decided to generate a triple mutant that contains null alleles corresponding 
to drh-1, rde-1 and rde-4.  I believe that this triple mutant will allow us to have a robust readout 
of loss of viral genome replication in diverse genetic conditions. 
The generation of drh-1; rde-1; rde-4 triple mutant began with the genetic cross between the single 
mutants to generate the double mutants, 11;drh1; rde1, 11;drh1; rde4 and 11;rde1; rde4.  The 
double mutants were then crossed to each other to generate triple mutant 11;drh1; rde-1; rde-4. 
 
Figure 4.2. Generation of reporter worm strain 11; drh1; rde-1; rde-4 through genetic 
crosses. (A) Schematic of genetic cross strategy to get double mutants and triple mutants of 
11; drh1; rde1, 11; drh1; rde4, 11;rde1; rde4 and 11;drh1; rde-1; rde-4. As  reconfirmation, 
16 worms were picked up at step 3 and 60 worms were picked up at step 6 for further 
analyses. (B) rde-1 and rde-4 mutations were confirmed by Sanger sequencing, top sequence 
is wild type sequence, bottom sequence is the sequence from candidate progenies. The 
nucleotide in the red box represents point mutation. (C) drh-1 deletion mutation was 
confirmed by PCR combined with gel electrophoresis.  
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The genetic cross strategy was illustrated in Figure 4.2 A. The candidate double and triple mutants 
were confirmed by Sanger sequencing and gel electrophoresis (Figure 4.2. B and 4.2. C).  After 
heat induction, the viral replication level, manifested in the intensity of green fluorescence, in 
different genetic backgrounds was recorded and shown in Table 3.  We found that when heat 
induced for 45 minutes, all triple mutants produced whole-body green fluorescence while  
Table 3. Green fluorescence expression level among all worm mutants during different heat 
induction period times 
  
Green fluorescence was checked 24 hrs. after HI treatment.  Red fluorescence expression levels 
were not changed before and after HI treatment among all mutants. 
HI: heat induction. GF: green fluorescence  
 
approximately half of the double mutants produced bright green fluorescence. Single mutants 
barely express green fluorescence in their bodies.  Heat-induction treatment longer than 150 
minutes led to worm death for two possible reasons: first, high temperature is detrimental to worm 
growth; second, FR1gfp replication at high level disrupted basic cellular function, making it hard 
for the worms to survive. In the end, I adopted heat induction of 90 minutes as the standard 
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treatment for observation of loss of viral replication through the whole project. Since no major 
developmental defects were observed in the triple mutants with FR1gfp transgene, I concluded 
that the generation of 11; drh1; rde-1; rde-4 as the reporter of loss of viral replication is successful.  
4.2.1.2. Characterization of RNAi Response in the Reporter Worm Strain 
 
To confirm that antiviral RNAi is further compromised in the triple mutant reporter 
compared to the corresponding single and double mutants containing the same FR1gfp transgene, 
I heat induced those worms and checked FR1gfp replication through Northern blotting analyses. I 
reasoned that if antiviral is further compromised in the triple mutant reporter, I should detect 
enhanced viral replication in the triple mutants compared to the single and double mutants. Indeed, 
as shown in Figure 4.3 A, FR1gfp transcripts accumulated to the highest level compared to the rest 
of mutant strains, which is consistent to the observed green fluorescence intensity (Table 3).  We 
reproduced the result when Orsay virus was used to challenge the mutants (data not shown). It is 
also important note that the production of worm miRNA miR-58 remains unchanged in all of the 
mutants, which is consistent to the observation that the triple mutant reporter does not exhibit 
major developmental defects. 
To find out whether the triple mutant reporter has any residual classical RNAi activity I 
tested RNAi response for those mutants by subjecting them to dsRNA ingestion or injection. 
Whereas microinjection of unc22 dsRNA caused severe twitching phenotype to the progenies of 
wide type N2 worms no such a phenotype was observed in progenies produced by the triple 
mutants (data not shown). This result is consistent with the feeding RNAi phenotype when the 
worms were fed with E. coli food containing skn-1 dsRNA: the fed wildtype N2 worms produced 
dead eggs while the triple mutants did not produce any dead eggs (Figure 4.3. B). As 
reconfirmation, I also fed the worms with E. coli food expressing mCherry dsRNA, which causes 
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very penetrating silencing of the mCherry transgene reporter. As shown in Figure 4.3 C, mCherry 
dsRNA feeding led to strong mCherry silencing in wild type worms but not in the triple mutant 
reporter.  All these data together suggest that both antiviral RNAi pathway is further compromised 
in the triple mutants, making our reporter worm strain, which is drh-1;rde-1;rde-4 triple mutants 
containing FR1gfp transgene 11, an ideal reporter for the identification of worm genes required 
for FR1gfp replication in large-scale genetic screens.  Since Orsay virus is closely related to FHV, 
my work may also lead to the identification of genes required for Orsay virus  genome replication.  
 
 
 
 
Figure 4.3. Characterization of RNAi response in the reporter worm strain. A, FR1gfp RNA 
accumulation detected by Northern blot in different genetic backgrounds as indicated. Total 
RNAs were extracted 24hr post-heat induction. All of the worm strains contain the same 
FR1gfp transgene termed 11.  B and C, Classical RNAi triggered by skn-1 dsRNA feeding (B) 
or mChery dsRNA feeding (C) in wildtype N2 worms or my triple mutants.  
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4.2.2. Identification of Genetic Alleles that Compromise FHV Genome Replication through 
Genome-wide Genetic Screen 
 
          To identify host factors required for FHV genome replication in C. elegans, a forward 
genetic screen was carried out using 11; drh-1; rde-1; rde-4 as reporter worm strain (11 here stands 
for the FR1gfp replicon transgene). In my study, L4 and young-adult hermaphrodites collected 
from large plates were treated with EMS and designated as P0 generation. In order to reduce allele 
duplicates, F1 adult worms were bleached to collect F2 eggs, which will hatch on fresh large plates. 
I used 90 min heat induction treatment to initiate FR1gfp replication in F2 adults and checked 
green fluorescence 24 hrs after heat induction (Figure 4.4. A). F2 worms that showed reduced or 
no green fluorescence were picked up for reconfirmation. Altogether 10 batches of worms were 
treated and screened in order to get a large number of candidate mutants for further analyses. 
Approximately 100 million F2 worms were screened, with 16 independent alleles identified. I 
named the candidate alleles as virus replication defective (vrd) alleles. As shown in Table 4, 
mutations in candidate alleles led to different GFP expression level and distinct phenotypes in 
worm development. Mutants B1, B2, C3, E3 and I4 did not show green fluorescence at all, while 
mutants A1, C2, D1, D4, I3, K2 and K3 showed green fluorescence only in the head. The 
remaining alleles produced weak green fluorescence on worm body. Mutant A1 grows extremely 
slowly and produces very few eggs. Mutants B1, C3, D4 and I4 had problems to lay eggs, resulting 
in egg hatching inside the gonad. The K2 adults have a reduced in the body size. These sever 
developmental phenotypes suggest that the corresponding candidate genes play essential role in 
worm growth and development.  
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To rule out the possibility that loss of FR1gfp replication is a result of transcriptional gene 
silencing targeting the reporter transgene array I checked the expression of mCherry transgene.   
The mCherry transgene is physically associated with the FR1gfp replicon transgene and would 
have been silenced if transcriptional silencing triggered by genetic mutation has occurred in the 
FR1gfp transgene array, considering that transcriptional silencing often spreads to adjacent genes. 
However, mCherry expression, manifested as red fluorescence, in all candidate mutants is not 
 
Figure 4.4. Identification of genetic alleles that compromise virus genome replication through 
genome-wide genetic screen.  A. Workflow of the genome-wide genetic screen strategy. 
EMS: Ethyl methanesulfonate mutagenesis. +: wildtype allele. m: mutant allele generated by 
EMS treatment. (B) Comparison of green fluorescence intensities among wildtype worms 
(11;N2), reporter worms (11; drh1; rde-1; rde-4) and candidate mutants 11; drh1; rde-1; rde-
4;x, x stands for the unknown candidate gene. All worms were treated at 33℃ for 90 minutes. 
The images were created by stacking pictures taken under different lighting conditions 24 hrs 
post heat induction. 
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compromised compared to the untreated reporter worms (Table 4). I also performed qRT-PCR to 
check the transcription of FR1gfp replicon. The result (data not shown) suggests that the 
transcription efficiency for the FR1gfp replicon remains the same as the untreated worms. Thus, 
the reduced green fluorescence expression is due to the mutations in genes required for FR1gfp 
replication. 
Table 4. Loss of FHV genome replication alleles isolated in the genetic screen 
 
a Red asterisk represents the mCherry expression level in all candidates. The mCherry expression 
level in 11; drh1;rde1;rde4 mutant serves as reference. 
b Green asterisk represents the GFP expression level. Candidate worm tissues that show GFP were  
labelled in the parenthesis. 11; drh1;rde1;rde4 mutant was used as a reference.  
c Candidate mutants that are sterile at 25℃ are defined as temperature-sensitive mutants 
 
4.2.3. Characterization of Candidate Alleles through Genetic Complementation Assay 
 
To determine the dominance of the vrd alleles, I crossed each of vrd mutants with original 
reporter worm strain 11; drh-1; rde-1; rde-4 and checked the loss of green fluorescence in F2 
Candidate gene Allele 
Intensity of 
mCherry a Intensity of GFPb 
Temp 
sensitivityc Developmental defect 
vrd-1 A1 **** *(head) N/A Dead eggs 
vrd-2 B1 **** N/A N/A Fertile eggs internally  
vrd-3 B2 **** N/A N/A N/A 
 C1 **** N/A (weak head) N/A N/A 
 E3 **** N/A N/A N/A 
vrd-4 C2 **** **(head) N/A Grow slow 
vrd-5 C3 **** N/A N/A Fertile eggs internally  
vrd-6 D1 **** N/A (weak head) N/A Dead eggs & grow slow 
 D2 **** N/A N/A Dead eggs & grow slow 
vrd-7 D4 **** *(head) N/A Fertile eggs internally  
vrd-8 I3 **** *(head) N/A Grow slow 
vrd-9 I4 **** N/A N/A Fertile eggs internally  
vrd-10 J1 **** *(weak body) N/A N/A 
vrd-11 K1 **** N/A (weak intestine) N/A N/A 
vrd-12 K2 **** *(head) N/A Shorter & fatter 
vrd-13 K3 **** *(head) N/A N/A 
11; N2  **** N/A (weak head) N/A N/A 
11; drh1; rde1; rde4  **** ****(whole body) N/A N/A 
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generations after heat induction. This test confirmed that all the vrd alleles were passed on as a 
simple recessive allele (data not shown). Genetic complementation test is used to determine if two 
mutant alleles belong to the same gene. In my study, the complementation phenomenon, the 
restoration of FR1gfp replication in F1 worms, will only occur when the mutant alleles in the P0 
parents belong to different genes. However, if the cross is between two vrd mutants that carry 
mutant alleles derived from the same gene, heat-induced F1 will still show reduced green 
fluorescence like heat induced P0 worms. Most of the genetic crosses between the candidate 
mutants were successful. However, it was difficult to conduct genetic crosses between some vrd 
mutants due to severe developmental defects. My genetic complementation tests successfully 
assigned C1, B2 and E3 to vrd-3 and D1 and D2 to vrd-6. The rest 11 candidate alleles may be 
derived from distinct genes (Table 5 and Table 6). 
  Table 5. Genetic complementation assay for the candidate alleles 
 
✕:  F1 worms generated from the crossing between candidates produced bright green fluorescence 
after heat induction, indicating that the corresponding candidate alleles belong to distinct genes. 
✓: F1 worms generated from the crossing between candidates produced weak or no green 
fluorescence after heat induction, indicating that the corresponding candidate alleles belong to the 
same gene.  
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To rule out the possibility that the loss of FR1gfp replication is due to enhanced RNAi 
response in the mutants, I performed dsRNA feeding to target both endogenous gene skn-1 and 
transgene mCherry. If the RNAi response in vrd mutants is restored I should be able to see 
silencing phenotypes like that in wildtype worms. Wildtype worms fed with skn-1 dsRNA results 
in dead egg phenotype whereas mCherry dsRNA feeding triggered potent silencing of the mCherry 
transgene, manifested as loss of red fluorescence in body wall muscle. However, as shown in Table 
6, none of my vrd mutants were  affected compared to the reporter worms fed with the same E.coli 
food. These results together suggest that the loss of FR1gfp replication in all vrd mutants is indeed 
a result of genetic mutations that occurred on genes required for FR1gfp replication  
 Table 6. Sensitivity of the identified mutants to feeding RNAi targeting skn-1 or mCherry 
 
 
 
 
 
 
 
 
 
 
 
 
aThe sensitivity to skn-1 dsRNA feeding was recorded as whether the eggs laid by the treated 
worms can hatch. -, not sensitive; + sensitive. 
bThe sensitivity to mCherry dsRNA feeding was recorded as whether the red fluorescence can be 
silenced on the treated worms. 
Candidate gene Allele 
sensitivity to skn-1  
dsRNA feeding a 
sensitivity to mCherry 
dsRNA feeding b 
vrd-1 A1 ⎯ ⎯ 
vrd-2 B1 ⎯ ⎯ 
vrd-3 B2 ⎯ ⎯ 
 C1 ⎯ ⎯ 
 E3 ⎯ ⎯ 
vrd-4 C2 ⎯ ⎯ 
vrd-5 C3 ⎯ ⎯ 
vrd-6 D1 ⎯ ⎯ 
 D2 ⎯ ⎯ 
vrd-7 D4 ⎯ ⎯ 
vrd-8 I3 ⎯ ⎯ 
vrd-9 I4 ⎯ ⎯ 
vrd-10 J1 ⎯ ⎯ 
vrd-11 K1 ⎯ ⎯ 
vrd-12 K2 ⎯ ⎯ 
vrd-13 K3 ⎯ ⎯ 
11; N2  + + 
11; drh1;rde1;rde4  ⎯ ⎯ 
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Northern blot analyses were performed to detect FR1gfp replication level in all vrd 
mutants. Total RNA samples were extracted 24 hrs after heat induction and the labeled probe was 
prepared to specifically target the GFP sequence in FR1gfp. As shown in Figure 4.5 A, virus 
transcripts accumulated to high level in 11; drh-1; rde-1; rde-4 reporter worms but became barely 
detectable in wildtype N2 worms containing the same FR1gfp transgene 11. I found that, consistent 
with the GFP intensity observed, FR1gfp transcripts accumulated to much lower level in vrd 
mutants. In particular, very low virus replication level was detected in B1, B2, C1, D1, D2 and I4 
mutants. Interestingly, of these strong candidates, B2, C1 and E3 were assigned to the same gene 
vrd-3, while D1 and D2 were assigned to vrd-6 in genetic complementation tests. It was also clear 
that no virus-derived siRNAs accumulated in any of the vrd mutants and the biogenesis 
and/stability of miRNAs remains unchanged in those mutants (Figure 4.5. B), further confirming 
that the RNAi activity in all of my vrd mutants is not restored.  
4.2.4. Identification of Candidate Genes Required for Orsay Virus Infection 
 
The fact that Orsay virus is closely related to FHV suggests that some of the vrd genes may 
also contribute to Orsay virus genome replication. To test this hypothesis, I challenged all of my 
vrd mutants with Orsay virus, expecting to identify worm genes required for Orsay virus genome 
replication. Unlike FR1gfp, which is an artificial virus to C. elegans, Orsay virus is a natural viral 
pathogen of C. elegans. Identification of genes required for Orsay virus genome replication will 
allow for in-depth study of viral genome replication in nematode worms under natural conditions. 
The entire life cycle of Orsay virus involves cell entry, uncoating, disassembly, 
translation/replication, encapsulations, and exit from infected cells. Genetic changes that disrupt 
virus-host interaction at each of these steps will inhibit Orsay virus infection, leading to reduced 
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viral transcripts in inoculated worms. After Orsay virus prepared from JU1580, a wild isolate that 
is susceptible to Orsay virus infection, was used to challenge the vrd mutants I found that the 
accumulation of Orsay virus genomic RNAs was reduced to different extents in all vrd mutants 
(Figure 4.5. C). This result suggests that some of my vrd genes also play important role in enabling 
Orsay virus infection. 
 
 
 
 
 
Figure 4.5. Identification of worm genes required for Orsay virus replication. (A) FHV 
genomic and sub-genomic RNA accumulation as detected using Northern blot in all vir 
mutants. Ribosomal RNAs stained with methylene blue serves as equal loading control. (B)  
Detection of FR1gfp-derived siRNAs in vir mutants. Viral siRNAs can be detected only in 
11; drh1;rde1 but not in any of the vir mutants. Worm miRNA miR-58 was detected and 
used as loading control. (C)The accumulation of Orsay virus RNA1 was detected by Northern 
blot in all vir mutants.  11; N2 and 11;drh1;rde1;rde4 were included in the tests as controls. 3 
independent replicates were carried out for each experiment.  
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4.2.5. Function Characterization of the Candidate Genes in the Context of Orsay Virus Genome 
Replication 
 
The fact that the replication of FR1gfp replicon does not involve an extracellular phase 
suggests that all of the vrd genes I identified should contribute to the genome replication of Orsay 
virus (for class IV viruses, the genome replication and transcription is the same process and very 
likely involves the same set of viral/host factors. Thus, I assume Orsay virus genome replication 
and transcription require the same set of host factors. To test this hypothesis, I decided to introduce 
Orsay virus into vrd mutants as transgene and check the Orsay virus replication in the resulting 
worm strains after heat induction. Like that in FR1gfp replicon construct, the Orsay virus replicon 
will also be under the control of heat inducible promoter (Figure 4.6. A). Therefore, the replication 
of Orsay virus can be easily started by a simple temperature shift (Figure 4.6. A). Since transgene-
mediated virus delivery bypasses the cell entry step, viral infection initiated from transgene will 
be compromised only in worm mutants that are unable to support virus genome replication. I 
reasoned that if any of the vrd genes specifically contribute to Orsay virus genome replication, 
Orsay virus infection initiated from transgene will remain defective in the corresponding mutants.  
Upon finishing gonad injection using a combination of plasmids harboring Orsay virus 
RNA1 and RNA2 replicon (Figure 4.6. B) I generated an integrated transgene array termed 46. In 
response to heat induction, both Orsay virus genomic RNAs were detected at high level in worm 
mutants containing loss of antiviral RNAi alleles drh-1, B01, 1028F and 1028J  (Figure 4.5. C). 
In wildtype N2 worms containing the 46 transgene Orsay virus genomic RNAs were barely 
detectable, presumably due to the antiviral RNAi response. 
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To find out whether any of the identified vrd genes are required for Orsay virus genome 
replication I introduced the 46 transgene into 13 of the 16 vrd mutants through genetic crosses. 
The rest of 3 vrd mutants exhibit server developmental defects, making it impossible to complete 
the cross. As shown in Figure 4.6 D, in response to heat induction the accumulation of Orsay virus 
 
Figure 4.6. Characterization of vrd genes required for Orsay virus replication.  A. Constructs 
of pHIP_RNA1 and pHIP_RNA2 were made by cloning Orsay virus RNA1 and RNA2 
cDNAs into a plasmid vector under the control of a heat-inducible promoter (HIP). A self-
cleaving hepatitis D virus ribozyme (RZ) sequence was fused to the 3’ end viral sequence to 
remove polyA tails produced during viral genome transcription. (B) Strategy for transgene-
mediated delivery of Orsay virus in C. elegans. Both pHIP_RNA1 and pHIP_RNA2 were 
injected, together with a selection marker, into target worms to generate a transgene array. 
(C) Northern blot detection of Orsay virus replication in RNAi defective mutants that contain 
an Orsay virus transgene array, termed 46, after heat induction. (D) Detection of Orsay virus 
replication in vrd mutants after heat induction. All the the vrd mutants contain the 46 
transgenes. 
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RNA1 in those 13 vrd mutants was significantly reduced compared to the original reporter worms 
containing the same 46 transgene.  
So far, only viro-2, sid-3 and drl-1 are identified as worm genes required for Orsay virus 
infection. However, Orsay virus infection initiated from transgene was not affected in worm 
mutants corresponding to these 3 genes, suggesting that none of these 3 genes contributes to the 
intracellular phase of Orsay virus life cycle. To find out whether some of my vrd mutants contain 
loss of function alleles derived from those 3 genes I amplified and sequenced viro-2 and sid-3 
cDNA sequences from all of my vrd mutants and checked if they are contained loss of function 
mutations. No loss of function alleles were identified for viro-1 or sid-3 in my vrd mutants. These 
results together further suggest that my genome-wide genetic screen has successfully identified 
some worm genes required for Orsay virus genome replication. 
4.3. Discussion 
 
In this project, I designed a genetic screen strategy to identify novel genes required for viral 
replication. This strategy utilizes chemical mutagenesis and a triple mutant worm containing the 
FR1gfp replicon as reporter of loss of FR1gfp genome replication. 16 viable mutants exhibiting 
lower (compared to the wild type worms) or no green fluorescence were isolated from the genetic 
screen compared to the wild type worm. Since the expression of green fluorescence is initiated 
from the FR1gfp transgene, which is carried by all worms, the loss of green fluorescence is a direct 
readout of failure in viral genome replication in my genetic screen. Hence, only those genes that 
specifically contribute to FR1gfp genome replication will be picked up. Through genetic 
complementation test, I assigned these mutants into over 10 genes as requirements of virus 
infection in C. elegans. Importantly, most of these genes are required for Orsay virus replication 
initiated from transgene, which has bypassed the cell entry step in Orsay virus life cycle. This 
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finding thus suggests that most of the candidate genes directly contribute to Orsay virus genome 
replication. To my knowledge, this is the first effort made to identify host genes involved in viral 
genome replication in nematodes. Virus-host interaction in nematodes has been poorly explored 
compared to other systems mainly due to the fact that the first viral pathogen for nematodes, the 
Orsay virus, was discovered 9 years ago.  The identification of novel genes involved in Orsay virus 
genome replication has laid solid foundation for in-depth study virus-host interaction in the context 
of virus genome replication. 
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Chapter 5.  General Discussion 
 
5.1. Novel Candidate Genes Required for Antiviral Immunity in C. elegans 
 
 Artificial dsRNAs trigger potent silencing of homologous cellular transcripts in diverse 
organisms. Mechanistic studies of this phenomenon, often referred to as classical RNAi, have 
significantly improved our understanding on antiviral immunity mediated by RNAi. However, 
several lines of evidence suggest that viruses as triggers and targets of RNAi are fundamentally 
different from the triggers and targets of classical RNAi. First, viruses often replicate in subcellular 
compartments, and accordingly virus-produced dsRNAs may be physically isolated from Dicer 
and cofactors (Den Boon et al., 2010). This may explain why antiviral RNAi in C. elegans requires 
DRH-1, a functional homologue of mammalian virus sensors. Second, the nascent viral transcripts 
often become rapidly associated with viral structure proteins, such as the coat proteins, and thereby 
become protected from Ago-mediated cleavage. The fact that FR1gfp replication triggers potent 
silencing of homologous cellular transgenes in drh-1 mutants further suggests that replicating virus 
is more resistant to RNAi than cellular transcripts, even in the absence of viral structural protein 
(Guo et al., 2013a). These observations suggest that antiviral RNAi involves more genes than 
classical RNAi, and these genes can only be identified in genetic screens that utilize replicating 
virus as a loss-of-RNAi reporter. 
          drh-1 transcriptions are not induced in response to replication of FHV (Lu et al., 2009b). 
Currently, whether the function of DRH-1 in virus detection undergoes posttranslational regulation 
remains largely unknown. Recently, Choi and colleagues found that the C-terminal region of RIG-
I, which plays a crucial role in viral dsRNA detection, undergoes deacetylation to regulate its 
activity in virus sensing and that RIG-I deacetylation by HDAC6 (histone deacetylase 6) is critical 
for viral RNA detection (Choi et al., 2016). The residue targeted by HDAC6 for deacetylation is 
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within a KWK motif that is conserved in DRH-1. Since the KWK motif is required for the DRH-
1 function in antiviral RNAi, it would be interesting to check if DRH-1 also undergoes 
deacetylation at this particular residue and whether deacetylation of this residue is required for 
DRH-1 function. Nevertheless, this observation suggests that while its genetic identity awaits 
further characterization, asd-9, which is required for the biogenesis or stability of primary 
vsiRNAs (Figure 3.11. B), contributes to viral dsRNA detection by directly or indirectly regulating 
DRH-1 function. 
 rsd-6 was initially identified as one of the genes required for the systemic spreading of 
RNAi (Tijsterman et al., 2004). Its role in antiviral RNAi has never been reported previously. It 
was shown that meiotic chromosome disjunction is affected in rsd-6 mutants under stressful 
conditions (Han et al., 2008). Further study of this phenomenon revealed that rsd-6 helps maintain 
genome integrity in stressful environments by maintaining transgenerational inheritance of 
endogenous siRNA populations that promote genome silencing (44). Consistent with this, we 
found that all rsd-6 mutants isolated in our genetic screen produce fewer progenies at room 
temperature than wild-type worms. However, our rsd-6 mutants do not become completely sterile 
when reared at 25°C (Table 1). Probably other worm genes, such as rsd-2, partially compensate 
for the loss of rsd-6 function in maintaining genome integrity. The fact that rsd-6 is required for 
the biogenesis or stability of primary vsiRNAs (Figure 3.11. B) suggests that rsd-6 is required for 
the production of secondary vsiRNAs whose biogenesis relies on the production and function of 
primary vsiRNAs. In support of this hypothesis, rsd-6 was previously found to help maintain the 
population of a class of endogenous secondary siRNAs that target and silence genes involved in 
spermatogenesis (Sakaguchi et al., 2014). 
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Previously we have demonstrated that replicating virus is more resistant to RNAi than 
cellular transcripts (Guo et al., 2013a), suggesting that the secondary siRNA-mediated 
amplification mechanism is more important for RNAi to destroy replicating viruses than cellular 
transcripts. rde-10, rde-11 and rsd-2 are 3 genes that are required for the production of secondary 
siRNAs. Recently, it has been demonstrated that worm mutants corresponding to these genes 
remain sensitive to high dosage of dsRNA triggers (Yang et al., 2012; Zhang et al., 2012), 
suggesting that a secondary siRNA-mediated gene-silencing effect would not be detected in a 
classical RNAi screen where the dosage of the dsRNA trigger is high. In fact, we also observed 
that rrf-1 mutant is sensitive to RNAi triggered by ingestion or injection of dsRNA. These 
observations together suggest that some of our candidate genes that are dispensable for classical 
RNAi mainly contribute to the biogenesis and/or function of secondary siRNA in antiviral RNAi. 
We speculate that asd-2 is such an antiviral RNAi gene. Although its function is not required for 
the biogenesis or stability of primary vsiRNAs (Figure 3.11 B), asd-2 may contribute to the 
biogenesis and/or function of secondary vsiRNAs in antiviral RNAi.  
Surprisingly, 7 of the candidate genes that are dispensable for classical RNAi do not confer 
resistance to intestine infecting Orsay virus (Figure 3.10.). To rule out the possibility that these 
genes regulate the transcription of the FR1gfp replicon transgene, thereby suppressing the 
replication of FR1gfp, we tested the antiviral activity of candidate genes asd-4 and asd-7 using 
worms that contain an Orsay virus replicon transgene driven by a heat-inducible promoter. After 
heat induction we did not observe a significant increase in Orsay virus replication in asd-4 or asd-
7 mutants compared to wild-type worms. Currently, it remains possible that those genes mainly 
function in non-intestinal cells to confer virus-specific silencing. 
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5.2. Novel Candidate Genes Required for Viral Genome Replication in C. elegans 
 
Previously, David Wang and colleagues have carried out a genome-wide genetic screen, 
aiming to identify genes required for Orsay virus infection in C. elegans (Jiang et al., 2017; 
Sandoval et al., 2019).  In their setup, the reporter gene is a GFP transgene under the control of a 
promoter that is induced during Orsay virus infection. Since the expression of the GFP reporter 
only occurs in response to Orsay virus infection, worms that are not challenged by the virus, for 
example in case the E. coli food is virus free, will not produce green fluorescence, leading to false 
positive. Currently, exactly how that promoter is induced by Orsay virus infection remains largely 
unknown. Since the reporter gene is not carried by Orsay virus the loss of green fluorescence 
cannot serve as a direct readout of failure in viral genome replication. This may explain why only 
host genes required for cell entry were identified so far.  
Compared to David Wang’s setup, my setup for the genetic screen is advantageous in at 
least three aspects. First, also the most important, virus replication in my setup is initiated from a 
replicon transgene which is carried by all worms to be treated by mutagen. In response to heat 
induction, viral replication will be simultaneously initiated in all worms. Therefore, no false 
positive will occur due to the failure in initiating viral replication. Second, the GFP coding 
sequence is translated from a subgenome RNA, the RNA3, which is produced solely by replicating 
FR1gfp. Therefore, unlike that in David Wang’s setup, the loss of green fluorescence in my setup 
is a direct readout of failure in viral genome replication. Hence, only those genes that specifically 
contribute to FR1gfp genome replication will be picked up during my genetic screen. The third, 
instead using a single mutant for genetic screen like that by Wang’s group, I used a triple mutant 
containing the FR1gfp replicon as reporter of loss of FR1gfp genome replication. Because drh-1, 
rde-1 and rde-4 play distinct role in antiviral RNAi and there are parallel pathways mediating 
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antiviral RNAi, worms defective in these 3 genes exhibited the lowest antiviral activity compared 
to corresponding single and double mutants. Thus, my reporter worm strain is able to pick up, with 
extremely high sensitivity, genetic alleles that only partially compromise FR1gfp genome 
replication.   
FHV is a representative virus of the nodavirus family. Although sharing basic genome 
structure and replication strategy with FHV, Orsay virus does not exhibit high-level sequence 
similarity with FHV. In fact, the RdRP amino acid sequences for these two viruses only share  19%  
identity. Surprisingly, as shown in my study, most of the vrd genes identified in my screen also 
play a role in facilitating Orsay virus genome replication. This finding suggests that very likely a 
set of common host factors are share by distinct +ssRNA virus to enable their genome replication. 
Functional and mechanistic study of vrd genes may not only improve our understanding of how 
+ssRNA virus genome is replicated in general but also facilitate the development of antiviral  drugs 
with broad-spectrum antiviral activity. The emergence of new viruses with fast mutation rates, 
such as the covid-19 virus, further highlights the importance in developing antiviral drugs with 
broad-spectrum antiviral activity.  
          The small size, short life span and hermaphroditic reproduction make C. elegans an ideal 
model system for gene function identification through large-scale genetic screens. When coupled 
with a robust reporter the C. elegans system allows for rapid gene discovery with little cost on 
human labor and resources. Another advantage of the worm system is the availability of a large 
collection of well-characterized genetic mutants, which will make it possible to perform genetic 
screen in a noise-free background, just like what I did in this study. Now mapping-by-sequencing 
through whole genome sequencing has been made possible because of the invention of next 
generation sequencing.  I believe that a well-designed reporter system coupled with mapping-by-
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sequencing strategy will allow many small labs with limited resources to conduct rapid genetic 
dissections on various biological pathways.  
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